<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35176758</PMID><DateCompleted><Year>2022</Year><Month>03</Month><Day>16</Day></DateCompleted><DateRevised><Year>2023</Year><Month>11</Month><Day>05</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1522-9645</ISSN><JournalIssue CitedMedium="Internet"><Volume>43</Volume><Issue>11</Issue><PubDate><Year>2022</Year><Month>Mar</Month><Day>14</Day></PubDate></JournalIssue><Title>European heart journal</Title><ISOAbbreviation>Eur Heart J</ISOAbbreviation></Journal><ArticleTitle>Long COVID: post-acute sequelae of COVID-19 with a cardiovascular focus.</ArticleTitle><Pagination><StartPage>1157</StartPage><EndPage>1172</EndPage><MedlinePgn>1157-1172</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1093/eurheartj/ehac031</ELocationID><Abstract><AbstractText>Emerging as a new epidemic, long COVID or post-acute sequelae of coronavirus disease 2019 (COVID-19), a condition characterized by the persistence of COVID-19 symptoms beyond 3 months, is anticipated to substantially alter the lives of millions of people globally. Cardiopulmonary symptoms including chest pain, shortness of breath, fatigue, and autonomic manifestations such as postural orthostatic tachycardia are common and associated with significant disability, heightened anxiety, and public awareness. A range of cardiovascular (CV) abnormalities has been reported among patients beyond the acute phase and include myocardial inflammation, myocardial infarction, right ventricular dysfunction, and arrhythmias. Pathophysiological mechanisms for delayed complications are still poorly understood, with a dissociation seen between ongoing symptoms and objective measures of cardiopulmonary health. COVID-19 is anticipated to alter the long-term trajectory of many chronic cardiac diseases which are abundant in those at risk of severe disease. In this review, we discuss the definition of long COVID and its epidemiology, with an emphasis on cardiopulmonary symptoms. We further review the pathophysiological mechanisms underlying acute and chronic CV injury, the range of post-acute CV sequelae, and impact of COVID-19 on multiorgan health. We propose a possible model for referral of post-COVID-19 patients to cardiac services and discuss future directions including research priorities and clinical trials that are currently underway to evaluate the efficacy of treatment strategies for long COVID and associated CV sequelae.</AbstractText><CopyrightInformation>&#xa9; The Author(s) 2022. Published by Oxford University Press on behalf of European Society of Cardiology.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Raman</LastName><ForeName>Betty</ForeName><Initials>B</Initials><Identifier Source="ORCID">0000-0002-1239-9608</Identifier><AffiliationInfo><Affiliation>Division of Cardiovascular Medicine, Radcliffe Department of Medicine, Oxford Centre for Clinical Magnetic Resonance Research, University of Oxford, National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), Oxford University Hospitals NHS Foundation Trust, John Radcliffe Hospital, Headley Way, Oxford OX3 9DU, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bluemke</LastName><ForeName>David A</ForeName><Initials>DA</Initials><Identifier Source="ORCID">0000-0002-8323-8086</Identifier><AffiliationInfo><Affiliation>Department of Radiology, University of Wisconsin School of Medicine and Public Health, 3252 Clinical Science Center, 600 Highland Ave, Madison, WI 53792, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medical Physics, University of Wisconsin School of Medicine and Public Health, 3252 Clinical Science Center, 600 Highland Ave, Madison, WI 53792, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>L&#xfc;scher</LastName><ForeName>Thomas F</ForeName><Initials>TF</Initials><AffiliationInfo><Affiliation>Royal Brompton &amp; Harefield Hospitals and National Heart and Lung Institute, Imperial College, London, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Molecular Cardiology, University of Zurich, Zurich, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Neubauer</LastName><ForeName>Stefan</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0001-9017-5645</Identifier><AffiliationInfo><Affiliation>Division of Cardiovascular Medicine, Radcliffe Department of Medicine, Oxford Centre for Clinical Magnetic Resonance Research, University of Oxford, National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), Oxford University Hospitals NHS Foundation Trust, John Radcliffe Hospital, Headley Way, Oxford OX3 9DU, UK.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><Agency>National Institute for Health Research</Agency><Country/></Grant><Grant><Agency>Oxford Biomedical Research Centre</Agency><Country/></Grant><Grant><GrantID>RE/18/3/34214</GrantID><Agency>Oxford British Heart Foundation (BHF) Centre of Research Excellence</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Eur Heart J</MedlineTA><NlmUniqueID>8006263</NlmUniqueID><ISSNLinking>0195-668X</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006331" MajorTopicYN="Y">Heart Diseases</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009205" MajorTopicYN="Y">Myocarditis</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Cardiovascular disease</Keyword><Keyword MajorTopicYN="N">Coronavirus</Keyword><Keyword MajorTopicYN="N">Long COVID</Keyword><Keyword MajorTopicYN="N">Long term</Keyword><Keyword MajorTopicYN="N">Post-acute sequelae of COVID-19</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>9</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2021</Year><Month>12</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>1</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>2</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>3</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>2</Month><Day>17</Day><Hour>20</Hour><Minute>18</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>2</Month><Day>18</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35176758</ArticleId><ArticleId IdType="pmc">PMC8903393</ArticleId><ArticleId IdType="doi">10.1093/eurheartj/ehac031</ArticleId><ArticleId IdType="pii">6529562</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Dong &#xa0;E, Du &#xa0;H, Gardner &#xa0;L. An interactive web-based dashboard to track COVID-19 in real time. Lancet Infect Dis &#xa0;2020;20:533&#x2013;534.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7159018</ArticleId><ArticleId IdType="pubmed">32087114</ArticleId></ArticleIdList></Reference><Reference><Citation>Long COVID: let patients help define long-lasting COVID symptoms. Nature &#xa0;2020;586:170.</Citation><ArticleIdList><ArticleId IdType="pubmed">33029005</ArticleId></ArticleIdList></Reference><Reference><Citation>

Perego &#xa0;E, Callard &#xa0;F, Stras &#xa0;L, Melville-Johannesson &#xa0;B, Pope &#xa0;R, Alwan &#xa0;N. Why we need to keep using the patient made term &#x201c;Long Covid&#x201d;. https://blogs.bmj.com/bmj/2020/10/01/why-we-need-to-keep-using-the-patient-made-term-long-covid/ (1 October 2020).</Citation></Reference><Reference><Citation>
National Institute for Health and Care Excellence. COVID-19 rapid guideline: managing the long-term effects of COVID-19. NICE guideline [NG188]. https://www.nice.org.uk/guidance/ng188 (18 December 2020).</Citation><ArticleIdList><ArticleId IdType="pubmed">33555768</ArticleId></ArticleIdList></Reference><Reference><Citation>
World Health Organization. A clinical case definition of post COVID-19 condition by a Delphi consensus. https://www.who.int/publications/i/item/WHO-2019-nCoV-Post_COVID-19_condition-Clinical_case_definition-2021.1 (6 October 2021).</Citation></Reference><Reference><Citation>Nalbandian &#xa0;A, Sehgal &#xa0;K, Gupta &#xa0;A, Madhavan &#xa0;MV, McGroder &#xa0;C, Stevens &#xa0;JS, et al. &#xa0;Post-acute COVID-19 syndrome. Nat Med &#xa0;2021;27:601&#x2013;615.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8893149</ArticleId><ArticleId IdType="pubmed">33753937</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Aly &#xa0;Z, Xie &#xa0;Y, Bowe &#xa0;B. High-dimensional characterization of post-acute sequelae of COVID-19. Nature &#xa0;2021;594:259&#x2013;264.</Citation><ArticleIdList><ArticleId IdType="pubmed">33887749</ArticleId></ArticleIdList></Reference><Reference><Citation>Phillips &#xa0;S, Williams &#xa0;MA. Confronting our next national health disaster&#x2014;long-haul Covid. N Engl J Med &#xa0;2021;385:577&#x2013;579.</Citation><ArticleIdList><ArticleId IdType="pubmed">34192429</ArticleId></ArticleIdList></Reference><Reference><Citation>Nabavi &#xa0;N. Long covid: how to define it and how to manage it. BMJ &#xa0;2020;370:m3489.</Citation><ArticleIdList><ArticleId IdType="pubmed">32895219</ArticleId></ArticleIdList></Reference><Reference><Citation>Islam &#xa0;MF, Cotler &#xa0;J, Jason &#xa0;LA. Post-viral fatigue and COVID-19: lessons from past epidemics. Fatigue Biomed Health Behav &#xa0;2020;8:61&#x2013;69.</Citation></Reference><Reference><Citation>Lyons &#xa0;D, Frampton &#xa0;M, Naqvi &#xa0;S, Donohoe &#xa0;D, Adams &#xa0;G, Glynn &#xa0;K. Fallout from the COVID-19 pandemic&#x2014;should we prepare for a tsunami of post viral depression? &#xa0;Ir J Psychol Med &#xa0;2020;37:295&#x2013;300.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7431842</ArticleId><ArticleId IdType="pubmed">32408926</ArticleId></ArticleIdList></Reference><Reference><Citation>Hotchin &#xa0;N, Read &#xa0;R, Smith &#xa0;D, Crawford &#xa0;D. Active Epstein-Barr virus infection in post-viral fatigue syndrome. J Infect &#xa0;1989;18:143&#x2013;150.</Citation><ArticleIdList><ArticleId IdType="pubmed">2540242</ArticleId></ArticleIdList></Reference><Reference><Citation>Bond &#xa0;P. A role for herpes simplex virus in the aetiology of chronic fatigue syndrome and related disorders. Med Hypotheses &#xa0;1993;40:301&#x2013;308.</Citation><ArticleIdList><ArticleId IdType="pubmed">8394501</ArticleId></ArticleIdList></Reference><Reference><Citation>Moldofsky &#xa0;H, Patcai &#xa0;J. Chronic widespread musculoskeletal pain, fatigue, depression and disordered sleep in chronic post-SARS syndrome; a case-controlled study. BMC Neurol &#xa0;2011;11:1&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3071317</ArticleId><ArticleId IdType="pubmed">21435231</ArticleId></ArticleIdList></Reference><Reference><Citation>Carod-Artal &#xa0;FJ. Post-Ebolavirus disease syndrome: what do we know? &#xa0;Expert Rev Anti Infect Ther &#xa0;2015;13:1185&#x2013;1187.</Citation><ArticleIdList><ArticleId IdType="pubmed">26293407</ArticleId></ArticleIdList></Reference><Reference><Citation>Sudre &#xa0;CH, Murray &#xa0;B, Varsavsky &#xa0;T, Graham &#xa0;MS, Penfold &#xa0;RS, Bowyer &#xa0;RC, et al. &#xa0;Attributes and predictors of long COVID. Nat Med &#xa0;2021;27:626&#x2013;631.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7611399</ArticleId><ArticleId IdType="pubmed">33692530</ArticleId></ArticleIdList></Reference><Reference><Citation>Whitaker &#xa0;M, Elliott &#xa0;J, Chadeau-Hyam &#xa0;M, Riley &#xa0;S, Darzi &#xa0;A, Cooke &#xa0;G, et al. &#xa0;Persistent symptoms following SARS-CoV-2 infection in a random community sample of 508,707 people. medRxiv &#xa0;2021. doi: 10.1101/2021.06.28.21259452</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2021.06.28.21259452</ArticleId></ArticleIdList></Reference><Reference><Citation>
Office for National Statistics. Prevalence of ongoing symptoms following coronavirus (COVID-19) infection in the UK. https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/bulletins/prevalenceofongoingsymptomsfollowingcoronaviruscovid19infectionintheuk/1april2021 (1 April 2021).</Citation></Reference><Reference><Citation>Evans &#xa0;RA, McAuley &#xa0;H, Harrison &#xa0;EM, Shikotra &#xa0;A, Singapuri &#xa0;A, Sereno &#xa0;M, et al. &#xa0;Physical, cognitive, and mental health impacts of COVID-19 after hospitalisation (PHOSP-COVID): a UK multicentre prospective cohort study. Lancet Respir Med &#xa0;2021;9:1275&#x2013;1287.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8497028</ArticleId><ArticleId IdType="pubmed">34627560</ArticleId></ArticleIdList></Reference><Reference><Citation>Augustin &#xa0;M, Schommers &#xa0;P, Stecher &#xa0;M, Dewald &#xa0;F, Gieselmann &#xa0;L, Gruell &#xa0;H, et al. &#xa0;Post-COVID syndrome in non-hospitalised patients with COVID-19: a longitudinal prospective cohort study. Lancet Reg Health Eur &#xa0;2021;6:100122.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8129613</ArticleId><ArticleId IdType="pubmed">34027514</ArticleId></ArticleIdList></Reference><Reference><Citation>See&#xdf;le &#xa0;J, Waterboer &#xa0;T, Hippchen &#xa0;T, Simon &#xa0;J, Kirchner &#xa0;M, Lim &#xa0;A, et al. &#xa0;Persistent symptoms in adult patients one year after COVID-19: a prospective cohort study. Clin Infect Dis &#xa0;2021. doi:10.1093/cid/ciab611</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciab611</ArticleId><ArticleId IdType="pmc">PMC8394862</ArticleId><ArticleId IdType="pubmed">34223884</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang &#xa0;C, Huang &#xa0;L, Wang &#xa0;Y, Li &#xa0;X, Ren &#xa0;L, Gu &#xa0;X, et al. &#xa0;6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. Lancet &#xa0;2021;397:220&#x2013;232.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7833295</ArticleId><ArticleId IdType="pubmed">33428867</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang &#xa0;L, Yao &#xa0;Q, Gu &#xa0;X, Wang &#xa0;Q, Ren &#xa0;L, Wang &#xa0;Y, et al. &#xa0;1-year outcomes in hospital survivors with COVID-19: a longitudinal cohort study. Lancet &#xa0;2021;398:747&#x2013;758.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8389999</ArticleId><ArticleId IdType="pubmed">34454673</ArticleId></ArticleIdList></Reference><Reference><Citation>

Dryden &#xa0;M, Vika &#xa0;C. Post acute sequelae of SARS-CoV-2 infection (PASC)&#x2014;formally long COVID. https://www.nioh.ac.za/wp-content/uploads/2021/04/NIOH-Webinar-Invitation_-COVID-19-_Long-Covid-and-the-workplace_22-April-2021-Dr-Dryden.pdf (21 April 2021).</Citation></Reference><Reference><Citation>Naik &#xa0;S, Soneja &#xa0;M, Haldar &#xa0;S, Soneja &#xa0;M, Mundadan &#xa0;NG, Garg &#xa0;P, et al. &#xa0;Post COVID-19 sequelae: a prospective observational study from Northern India. Drug Discov Ther &#xa0;2021;15:254&#x2013;260.</Citation><ArticleIdList><ArticleId IdType="pubmed">34719599</ArticleId></ArticleIdList></Reference><Reference><Citation>Chopra &#xa0;N, Chowdhury &#xa0;M, Singh &#xa0;AK, Ma &#xa0;K, Kumar &#xa0;A, Ranjan &#xa0;P, et al. &#xa0;Clinical predictors of long COVID-19 and phenotypes of mild COVID-19 at a tertiary care centre in India. Drug Discov Ther &#xa0;2021;15:156&#x2013;161.</Citation><ArticleIdList><ArticleId IdType="pubmed">34234065</ArticleId></ArticleIdList></Reference><Reference><Citation>Mahmud &#xa0;R, Rahman &#xa0;MM, Rassel &#xa0;MA, Monayem &#xa0;FB, Sayeed &#xa0;SJB, Islam &#xa0;MS, et al. &#xa0;Post-COVID-19 syndrome among symptomatic COVID-19 patients: a prospective cohort study in a tertiary care center of Bangladesh. PLoS One &#xa0;2021;16:e0249644.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8031743</ArticleId><ArticleId IdType="pubmed">33831043</ArticleId></ArticleIdList></Reference><Reference><Citation>Hossain &#xa0;MA, Hossain &#xa0;KMA, Saunders &#xa0;K, Uddin &#xa0;Z, Walton &#xa0;LM, Raigangar &#xa0;V, et al. &#xa0;Prevalence of long COVID symptoms in Bangladesh: a prospective inception cohort study of COVID-19 survivors. BMJ Glob Health &#xa0;2021;6:e006838.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8671853</ArticleId><ArticleId IdType="pubmed">34906986</ArticleId></ArticleIdList></Reference><Reference><Citation>Lund &#xa0;LC, Hallas &#xa0;J, Nielsen &#xa0;H, Koch &#xa0;A, Mogensen &#xa0;SH, Brun &#xa0;NC, et al. &#xa0;Post-acute effects of SARS-CoV-2 infection in individuals not requiring hospital admission: a Danish population-based cohort study. Lancet Infect Dis &#xa0;2021;21:1373&#x2013;1382.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8110209</ArticleId><ArticleId IdType="pubmed">33984263</ArticleId></ArticleIdList></Reference><Reference><Citation>Venturelli &#xa0;S, Benatti &#xa0;SV, Casati &#xa0;M, Binda &#xa0;F, Zuglian &#xa0;G, Imeri &#xa0;G, et al. &#xa0;Surviving COVID-19 in Bergamo province: a post-acute outpatient re-evaluation. Epidemiol Infect &#xa0;2021;149:e32.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7873454</ArticleId><ArticleId IdType="pubmed">33461632</ArticleId></ArticleIdList></Reference><Reference><Citation>Bellan &#xa0;M, Soddu &#xa0;D, Balbo &#xa0;PE, Baricich &#xa0;A, Zeppegno &#xa0;P, Avanzi &#xa0;GC, et al. &#xa0;Respiratory and psychophysical sequelae among patients with COVID-19 four months after hospital discharge. JAMA Netw Open &#xa0;2021;4:e2036142.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7841464</ArticleId><ArticleId IdType="pubmed">33502487</ArticleId></ArticleIdList></Reference><Reference><Citation>Logue &#xa0;JK, Franko &#xa0;NM, McCulloch &#xa0;DJ, McDonald &#xa0;D, Magedson &#xa0;A, Wolf &#xa0;CR, et al. &#xa0;Sequelae in adults at 6 months after COVID-19 infection. JAMA Netw Open &#xa0;2021;4:e210830.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7896197</ArticleId><ArticleId IdType="pubmed">33606031</ArticleId></ArticleIdList></Reference><Reference><Citation>Hirschtick &#xa0;JL, Titus &#xa0;AR, Slocum &#xa0;E, Power &#xa0;LE, Hirschtick &#xa0;RE, Elliott &#xa0;MR, et al. &#xa0;Population-based estimates of post-acute sequelae of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection (PASC) prevalence and characteristics. Clin Infect Dis &#xa0;2021;73:2055&#x2013;2064.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8240848</ArticleId><ArticleId IdType="pubmed">34007978</ArticleId></ArticleIdList></Reference><Reference><Citation>Blomberg &#xa0;B, Mohn &#xa0;KG-I, Brokstad &#xa0;KA, Zhou &#xa0;F, Linchausen &#xa0;DW, Hansen &#xa0;B-A, et al. &#xa0;Long COVID in a prospective cohort of home-isolated patients. Nat Med &#xa0;2021;27:1607&#x2013;1613.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8440190</ArticleId><ArticleId IdType="pubmed">34163090</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu &#xa0;X, Liu &#xa0;X, Zhou &#xa0;Y, Yu &#xa0;H, Li &#xa0;R, Zhan &#xa0;Q, et al. &#xa0;3-month, 6-month, 9-month, and 12-month respiratory outcomes in patients following COVID-19-related hospitalisation: a prospective study. Lancet Resp Med &#xa0;2021;9:747&#x2013;754.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8099316</ArticleId><ArticleId IdType="pubmed">33964245</ArticleId></ArticleIdList></Reference><Reference><Citation>Cassar &#xa0;MP, Tunnicliffe &#xa0;EM, Petousi &#xa0;N, Lewandowski &#xa0;AJ, Xie &#xa0;C, Mahmod &#xa0;M, et al. &#xa0;Symptom persistence despite improvement in cardiopulmonary health&#x2014;insights from longitudinal CMR, CPET and lung function testing post-COVID-19. EClinicalMedicine &#xa0;2021;41:101159.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8527025</ArticleId><ArticleId IdType="pubmed">34693230</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis &#xa0;HE, Assaf &#xa0;GS, McCorkell &#xa0;L, Wei &#xa0;H, Low &#xa0;RJ, Re&#x2019;em &#xa0;Y, et al. &#xa0;Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. EClinicalMedicine &#xa0;2021;38:101019.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8280690</ArticleId><ArticleId IdType="pubmed">34308300</ArticleId></ArticleIdList></Reference><Reference><Citation>Thompson &#xa0;EJ, Williams &#xa0;DM, Walker &#xa0;AJ, Mitchell &#xa0;RE, Niedzwiedz &#xa0;CL, Yang &#xa0;TC, et al. &#xa0;Risk factors for long COVID: analyses of 10 longitudinal studies and electronic health records in the UK. medRxiv. doi: 10.1101/2021.06.24.21259277</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2021.06.24.21259277</ArticleId><ArticleId IdType="pmc">PMC9240035</ArticleId><ArticleId IdType="pubmed">35764621</ArticleId></ArticleIdList></Reference><Reference><Citation>
Office for National Statistics. Prevalence of ongoing symptoms following coronavirus (COVID-19) infection in the UK. https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/bulletins/prevalenceofongoingsymptomsfollowingcoronaviruscovid19infectionintheuk/4june2021 (4 June 2021).</Citation></Reference><Reference><Citation>
Office for National Statistics. Prevalence of ongoing symptoms following coronavirus (COVID-19) infection in the UK. 11 July 2021. https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/bulletins/prevalenceofongoingsymptomsfollowingcoronaviruscovid19infectionintheuk/1july2021 (15 August 202).</Citation></Reference><Reference><Citation>Murray &#xa0;CJ, Aravkin &#xa0;AY, Zheng &#xa0;P, Abbafati &#xa0;C, Abbas &#xa0;KM, Abbasi-Kangevari &#xa0;M, et al. &#xa0;Global burden of 87 risk factors in 204 countries and territories, 1990&#x2013;2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet &#xa0;2020;396:1223&#x2013;1249.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7566194</ArticleId><ArticleId IdType="pubmed">33069327</ArticleId></ArticleIdList></Reference><Reference><Citation>Grosso &#xa0;G. Obesity during COVID-19: an underrated pandemic? &#xa0;EClinicalMedicine &#xa0;2021;39:101062.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8342904</ArticleId><ArticleId IdType="pubmed">34386762</ArticleId></ArticleIdList></Reference><Reference><Citation>Horton &#xa0;R. Offline: COVID-19 is not a pandemic. Lancet &#xa0;2020;396:874.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7515561</ArticleId><ArticleId IdType="pubmed">32979964</ArticleId></ArticleIdList></Reference><Reference><Citation>
NHS Digital England. Health Survey for England 2019. https://digital.nhs.uk/data-and-information/publications/statistical/health-survey-for-england/2019 (October 2021).</Citation></Reference><Reference><Citation>
NHS Digital England. National child measurement programme 2019. https://digital.nhs.uk/data-and-information/publications/statistical/national-child-measurement-programme/2019-20-school-year (October 2021).</Citation></Reference><Reference><Citation>Virani &#xa0;SS, Alonso &#xa0;A, Aparicio &#xa0;HJ, Benjamin &#xa0;EJ, Bittencourt &#xa0;MS, Callaway &#xa0;CW, et al. &#xa0;Heart disease and stroke statistics&#x2014;2021 update. Circulation &#xa0;2021;143:e254&#x2013;e743.</Citation><ArticleIdList><ArticleId IdType="pubmed">33501848</ArticleId></ArticleIdList></Reference><Reference><Citation>Fogarty &#xa0;H, Townsend &#xa0;L, Morrin &#xa0;H, Ahmad &#xa0;A, Comerford &#xa0;C, Karampini &#xa0;E, et al. &#xa0;Persistent endotheliopathy in the pathogenesis of long COVID syndrome. J Thromb Haemost &#xa0;2021;19:2546&#x2013;2553.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8420256</ArticleId><ArticleId IdType="pubmed">34375505</ArticleId></ArticleIdList></Reference><Reference><Citation>Ritchie &#xa0;S, Connell &#xa0;J. The link between abdominal obesity, metabolic syndrome and cardiovascular disease. Nutr Metab Cardiovasc Dis &#xa0;2007;17:319&#x2013;326.</Citation><ArticleIdList><ArticleId IdType="pubmed">17110092</ArticleId></ArticleIdList></Reference><Reference><Citation>
Office of National Statistics. The prevalence of long COVID symptoms and COVID-19 complications. https://www.ons.gov.uk/news/statementsandletters/theprevalenceoflongcovidsymptomsandcovid19complications (16 December 2020).</Citation></Reference><Reference><Citation>
Office of National Statistics. Prevalence of ongoing symptoms following coronavirus (COVID-19) infection in the UK. https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/bulletins/prevalenceofongoingsymptomsfollowingcoronaviruscovid19infectionintheuk/2september2021 (2 September 2021).</Citation></Reference><Reference><Citation>Ziauddeen &#xa0;N, Gurdasani &#xa0;D, O&#x2019;Hara &#xa0;ME, Hastie &#xa0;C, Roderick &#xa0;P, Yao &#xa0;G, et al. &#xa0;Characteristics of long covid: findings from a social media survey. medRxiv &#xa0;2021. doi:10.1101/2021.03.21.21253968</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2021.03.21.21253968</ArticleId><ArticleId IdType="pmc">PMC8903286</ArticleId><ArticleId IdType="pubmed">35259179</ArticleId></ArticleIdList></Reference><Reference><Citation>Newman &#xa0;M. Chronic fatigue syndrome and long covid: moving beyond the controversy. BMJ &#xa0;2021;373:n1559.</Citation><ArticleIdList><ArticleId IdType="pubmed">34162532</ArticleId></ArticleIdList></Reference><Reference><Citation>Carfi &#xa0;A, Bernabei &#xa0;R, Landi &#xa0;F. Persistent symptoms in patients after acute COVID-19. JAMA &#xa0;2020;324:603&#x2013;605.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7349096</ArticleId><ArticleId IdType="pubmed">32644129</ArticleId></ArticleIdList></Reference><Reference><Citation>Carruthers &#xa0;BM, van de Sande &#xa0;MI, De Meirleir &#xa0;KL, Klimas &#xa0;NG, Broderick &#xa0;G, Mitchell &#xa0;T, et al. &#xa0;Myalgic encephalomyelitis: international consensus criteria. J Intern Med &#xa0;2011;270:327&#x2013;338.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3427890</ArticleId><ArticleId IdType="pubmed">21777306</ArticleId></ArticleIdList></Reference><Reference><Citation>Carruthers &#xa0;BM, Jain &#xa0;AK, De Meirleir &#xa0;KL, Peterson &#xa0;DL, Klimas &#xa0;NG, Lerner &#xa0;AM, et al. &#xa0;Myalgic encephalomyelitis/chronic fatigue syndrome: clinical working case definition, diagnostic and treatment protocols. J Chronic Fatigue Syndr &#xa0;2003;11:7&#x2013;115.</Citation></Reference><Reference><Citation>Singh &#xa0;SJ, Barradell &#xa0;AC, Greening &#xa0;NJ, Bolton &#xa0;C, Jenkins &#xa0;G, Preston &#xa0;L, et al. &#xa0;British Thoracic Society survey of rehabilitation to support recovery of the post-COVID-19 population. BMJ Open &#xa0;2020;10:e040213.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7712930</ArticleId><ArticleId IdType="pubmed">33268418</ArticleId></ArticleIdList></Reference><Reference><Citation>VanElzakker &#xa0;MB, Brumfield &#xa0;SA, Lara Mejia &#xa0;PS. Neuroinflammation and cytokines in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS): a critical review of research methods. Front Neurol &#xa0;2019;9:1033.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6335565</ArticleId><ArticleId IdType="pubmed">30687207</ArticleId></ArticleIdList></Reference><Reference><Citation>Cader &#xa0;S, O&#x2019;Donovan &#xa0;D, Shepherd &#xa0;C, Chaudhuri &#xa0;A. FP03-MO-02 neuropathology of post-infectious chronic fatigue syndrome. J Neurol Sci &#xa0;2009;285:S60&#x2013;S61.</Citation></Reference><Reference><Citation>VanElzakker &#xa0;MB. Chronic fatigue syndrome from vagus nerve infection: a psychoneuroimmunological hypothesis. Med Hypotheses &#xa0;2013;81:414&#x2013;423.</Citation><ArticleIdList><ArticleId IdType="pubmed">23790471</ArticleId></ArticleIdList></Reference><Reference><Citation>Douaud &#xa0;G, Lee &#xa0;S, Alfaro-Almagro &#xa0;F, Arthofer &#xa0;C, Wang &#xa0;C, McCarthy &#xa0;P, et al. &#xa0;Brain imaging before and after COVID-19 in UK Biobank. medRxiv &#xa0;2021. doi: 10.1101/2021.06.11.21258690</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2021.06.11.21258690</ArticleId></ArticleIdList></Reference><Reference><Citation>Edler &#xa0;C, Schroder &#xa0;AS, Aepfelbacher &#xa0;M, Fitzek &#xa0;A, Heinemann &#xa0;A, Heinrich &#xa0;F, et al. &#xa0;Dying with SARS-CoV-2 infection&#x2014;an autopsy study of the first consecutive 80 cases in Hamburg, Germany. Int J Legal Med &#xa0;2020;134:1275&#x2013;1284.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7271136</ArticleId><ArticleId IdType="pubmed">32500199</ArticleId></ArticleIdList></Reference><Reference><Citation>Basso &#xa0;C, Leone &#xa0;O, Rizzo &#xa0;S, De Gaspari &#xa0;M, van der Wal &#xa0;AC, Aubry &#xa0;MC, et al. &#xa0;Pathological features of COVID-19-associated myocardial injury: a multicentre cardiovascular pathology study. Eur Heart J &#xa0;2020;41:3827&#x2013;3835.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7543528</ArticleId><ArticleId IdType="pubmed">32968776</ArticleId></ArticleIdList></Reference><Reference><Citation>Halushka &#xa0;MK, Vander Heide &#xa0;RS. Myocarditis is rare in COVID-19 autopsies: cardiovascular findings across 277 postmortem examinations. Cardiovasc Pathol &#xa0;2021;50:107300.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7583586</ArticleId><ArticleId IdType="pubmed">33132119</ArticleId></ArticleIdList></Reference><Reference><Citation>Aretz H &#xa0;T. Myocarditis: the Dallas criteria. Hum Pathol &#xa0;1987;18:619&#x2013;624.</Citation><ArticleIdList><ArticleId IdType="pubmed">3297992</ArticleId></ArticleIdList></Reference><Reference><Citation>Fox &#xa0;SE, Vander Heide &#xa0;RS. COVID-19: the heart of the matter&#x2014;pathological changes and a proposed mechanism. J Cardiovasc Pharmacol Ther &#xa0;2021;26:217&#x2013;224.</Citation><ArticleIdList><ArticleId IdType="pubmed">33703938</ArticleId></ArticleIdList></Reference><Reference><Citation>Hooper &#xa0;JE, Padera &#xa0;RF, Dolhnikoff &#xa0;M, da Silva &#xa0;LFF, Duarte-Neto &#xa0;AN, Kapp &#xa0;ME, et al. &#xa0;A postmortem portrait of the coronavirus disease 2019 (COVID-19) pandemic: a large multi-institutional autopsy survey study. Arch Pathol Lab Med &#xa0;2021;145:529&#x2013;535.</Citation><ArticleIdList><ArticleId IdType="pubmed">33449998</ArticleId></ArticleIdList></Reference><Reference><Citation>Kawakami &#xa0;R, Sakamoto &#xa0;A, Kawai &#xa0;K, Gianatti &#xa0;A, Pellegrini &#xa0;D, Nasr &#xa0;A, et al. &#xa0;Pathological evidence for SARS-CoV-2 as a cause of myocarditis: JACC review topic of the week. J Am Coll Cardiol &#xa0;2021;77:314&#x2013;325.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7816957</ArticleId><ArticleId IdType="pubmed">33478655</ArticleId></ArticleIdList></Reference><Reference><Citation>Lindner &#xa0;D, Fitzek &#xa0;A, Br&#xe4;uninger &#xa0;H, Aleshcheva &#xa0;G, Edler &#xa0;C, Meissner &#xa0;K, et al. &#xa0;Association of cardiac infection with SARS-CoV-2 in confirmed COVID-19 autopsy cases. JAMA Cardiol &#xa0;2020;5:1281&#x2013;1285.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7385672</ArticleId><ArticleId IdType="pubmed">32730555</ArticleId></ArticleIdList></Reference><Reference><Citation>Giustino &#xa0;G, Croft &#xa0;LB, Stefanini &#xa0;GG, Bragato &#xa0;R, Silbiger &#xa0;JJ, Vicenzi &#xa0;M, et al. &#xa0;Characterization of myocardial injury in patients with COVID-19. J Am Coll Cardiol &#xa0;2020;76:2043&#x2013;2055.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7588179</ArticleId><ArticleId IdType="pubmed">33121710</ArticleId></ArticleIdList></Reference><Reference><Citation>Bois &#xa0;MC, Boire &#xa0;NA, Layman &#xa0;AJ, Aubry &#xa0;MC, Alexander &#xa0;MP, Roden &#xa0;AC, et al. &#xa0;COVID-19-associated nonocclusive fibrin microthrombi in the heart. Circulation &#xa0;2021;143:230&#x2013;243.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7805556</ArticleId><ArticleId IdType="pubmed">33197204</ArticleId></ArticleIdList></Reference><Reference><Citation>Vrints &#xa0;CJM, Krychtiuk &#xa0;KA, Van Craenenbroeck &#xa0;EM, Segers &#xa0;VF, Price &#xa0;S, Heidbuchel &#xa0;H. Endothelialitis plays a central role in the pathophysiology of severe COVID-19 and its cardiovascular complications. Acta Cardiol &#xa0;2021;76:109&#x2013;124.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7682384</ArticleId><ArticleId IdType="pubmed">33208052</ArticleId></ArticleIdList></Reference><Reference><Citation>Robinson &#xa0;FA, Mihealsick &#xa0;RP, Wagener &#xa0;BM, Hanna &#xa0;P, Poston &#xa0;MD, Efimov &#xa0;IR, et al. &#xa0;Role of angiotensin-converting enzyme 2 and pericytes in cardiac complications of COVID-19 infection. Am J Physiol Heart Circ Physiol &#xa0;2020;319:H1059&#x2013;H1068.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7789968</ArticleId><ArticleId IdType="pubmed">33036546</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang &#xa0;L, Xie &#xa0;X, Tu &#xa0;Z, Fu &#xa0;J, Xu &#xa0;D, Zhou &#xa0;Y. The signal pathways and treatment of cytokine storm in COVID-19. Signal Transduct Target Ther &#xa0;2021;6:255.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8261820</ArticleId><ArticleId IdType="pubmed">34234112</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu &#xa0;Z, Li &#xa0;S, Song &#xa0;X. Cytokine storm with rapidly elevated interleukin-6 indicates sudden death in patients with critical COVID-19. Cytokine Growth Factor Rev &#xa0;2021;58:30&#x2013;31.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7445135</ArticleId><ArticleId IdType="pubmed">32873506</ArticleId></ArticleIdList></Reference><Reference><Citation>Pollack &#xa0;A, Kontorovich &#xa0;AR, Fuster &#xa0;V, Dec &#xa0;GW. Viral myocarditis&#x2014;diagnosis, treatment options, and current controversies. Nat Rev Cardiol &#xa0;2015;12:670&#x2013;680.</Citation><ArticleIdList><ArticleId IdType="pubmed">26194549</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim &#xa0;HW, de Chantem&#xe8;le EJ &#xa0;B, Weintraub &#xa0;NL. Perivascular adipocytes in vascular disease. Arterioscler Thromb Vasc Biol &#xa0;2019;39:2220&#x2013;2227.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6812617</ArticleId><ArticleId IdType="pubmed">31510794</ArticleId></ArticleIdList></Reference><Reference><Citation>Blagova &#xa0;O, Varionchik &#xa0;N, Zaidenov &#xa0;V, Savina &#xa0;P, Sarkisova &#xa0;N. Anti-heart antibodies levels and their correlation with clinical symptoms and outcomes in patients with confirmed or suspected diagnosis COVID-19. Eur J Immunol &#xa0;2021;51:893&#x2013;902.</Citation><ArticleIdList><ArticleId IdType="pubmed">33368288</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang &#xa0;EY, Mao &#xa0;T, Klein &#xa0;J, Dai &#xa0;Y, Huck &#xa0;JD, Jaycox &#xa0;JR, et al. &#xa0;Diverse functional autoantibodies in patients with COVID-19. Nature &#xa0;2021;595:283&#x2013;288.</Citation><ArticleIdList><ArticleId IdType="pubmed">34010947</ArticleId></ArticleIdList></Reference><Reference><Citation>Franke &#xa0;C, Ferse &#xa0;C, Kreye &#xa0;J, Reincke &#xa0;SM, Sanchez-Sendin &#xa0;E, Rocco &#xa0;A, et al. &#xa0;High frequency of cerebrospinal fluid autoantibodies in COVID-19 patients with neurological symptoms. Brain Behav Immun &#xa0;2021;93:415&#x2013;419.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7834471</ArticleId><ArticleId IdType="pubmed">33359380</ArticleId></ArticleIdList></Reference><Reference><Citation>Richter &#xa0;AG, Shields &#xa0;AM, Karim &#xa0;A, Birch &#xa0;D, Faustini &#xa0;SE, Steadman &#xa0;L, et al. &#xa0;Establishing the prevalence of common tissue-specific autoantibodies following severe acute respiratory syndrome coronavirus 2 infection. Clin Exp Immunol &#xa0;2021;205:99&#x2013;105.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8239842</ArticleId><ArticleId IdType="pubmed">34082475</ArticleId></ArticleIdList></Reference><Reference><Citation>Konstantinov &#xa0;K, Von Mikecz &#xa0;A, Buchwald &#xa0;D, Jones &#xa0;J, Gerace &#xa0;L, Tan &#xa0;E. Autoantibodies to nuclear envelope antigens in chronic fatigue syndrome. J Clin Investig &#xa0;1996;98:1888&#x2013;1896.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC507629</ArticleId><ArticleId IdType="pubmed">8878441</ArticleId></ArticleIdList></Reference><Reference><Citation>Loebel &#xa0;M, Grabowski &#xa0;P, Heidecke &#xa0;H, Bauer &#xa0;S, Hanitsch &#xa0;LG, Wittke &#xa0;K, et al. &#xa0;Antibodies to &#x3b2; adrenergic and muscarinic cholinergic receptors in patients with Chronic Fatigue Syndrome. Brain Behav Immun &#xa0;2016;52:32&#x2013;39.</Citation><ArticleIdList><ArticleId IdType="pubmed">26399744</ArticleId></ArticleIdList></Reference><Reference><Citation>Talla &#xa0;A, Vasaikar &#xa0;SV, Lemos &#xa0;MP, Moodie &#xa0;Z, Pebworth &#xa0;M-PL, Henderson &#xa0;KE, et al. &#xa0;Longitudinal immune dynamics of mild COVID-19 define signatures of recovery and persistence. bioRxiv &#xa0;2021. doi: 10.1101/2021.05.26.442666</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2021.05.26.442666</ArticleId></ArticleIdList></Reference><Reference><Citation>von Meijenfeldt &#xa0;FA, Havervall &#xa0;S, Adelmeijer &#xa0;J, Lundstr&#xf6;m &#xa0;A, Magnusson &#xa0;M, Mackman &#xa0;N, et al. &#xa0;Sustained prothrombotic changes in COVID-19 patients 4 months after hospital discharge. Blood Adv &#xa0;2021;5:756&#x2013;759.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7857699</ArticleId><ArticleId IdType="pubmed">33560386</ArticleId></ArticleIdList></Reference><Reference><Citation>Garg &#xa0;A, Goyal &#xa0;S, Patel &#xa0;P. A case of COVID-19 infection with delayed thromboembolic complication on warfarin. Cureus &#xa0;2020;12:e8847.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7325392</ArticleId><ArticleId IdType="pubmed">32617244</ArticleId></ArticleIdList></Reference><Reference><Citation>Schweblin &#xa0;C, Hachulla &#xa0;AL, Roffi &#xa0;M, Glauser &#xa0;F. Delayed manifestation of COVID-19 presenting as lower extremity multilevel arterial thrombosis: a case report. Eur Heart J Case Rep &#xa0;2020;4:1&#x2013;4.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7717202</ArticleId><ArticleId IdType="pubmed">33437919</ArticleId></ArticleIdList></Reference><Reference><Citation>Vechi &#xa0;HT, Maia &#xa0;LR, MdM &#xa0;A. Late acute pulmonary embolism after mild Coronavirus Disease 2019 (COVID-19): a case series. Rev Inst Med Trop Sao Paulo &#xa0;2020;62:e63.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7477961</ArticleId><ArticleId IdType="pubmed">32901760</ArticleId></ArticleIdList></Reference><Reference><Citation>Riyahi &#xa0;S, Dev &#xa0;H, Behzadi &#xa0;A, Kim &#xa0;J, Attari &#xa0;H, Raza &#xa0;SI, et al. &#xa0;Pulmonary embolism in hospitalized patients with COVID-19: a multicenter study. Radiology &#xa0;2021;301:E426&#x2013;E433.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8294351</ArticleId><ArticleId IdType="pubmed">34254850</ArticleId></ArticleIdList></Reference><Reference><Citation>Suzuki &#xa0;YJ, Nikolaienko &#xa0;SI, Shults &#xa0;NV, Gychka &#xa0;SG. COVID-19 patients may become predisposed to pulmonary arterial hypertension. Med Hypotheses &#xa0;2021;147:110483.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7787059</ArticleId><ArticleId IdType="pubmed">33444904</ArticleId></ArticleIdList></Reference><Reference><Citation>Ambrosino &#xa0;P, Calcaterra &#xa0;I, Molino &#xa0;A, Moretta &#xa0;P, Lupoli &#xa0;R, Spedicato &#xa0;GA, et al. &#xa0;Persistent endothelial dysfunction in post-acute COVID-19 syndrome: a case-control study. Biomedicines &#xa0;2021;9:957.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8391623</ArticleId><ArticleId IdType="pubmed">34440161</ArticleId></ArticleIdList></Reference><Reference><Citation>Ratchford &#xa0;SM, Stickford &#xa0;JL, Province &#xa0;VM, Stute &#xa0;N, Augenreich &#xa0;MA, Koontz &#xa0;LK, et al. &#xa0;Vascular alterations among young adults with SARS-CoV-2. Am J Physiol Heart Circ Physiol &#xa0;2021;320:H404&#x2013;H410.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8083172</ArticleId><ArticleId IdType="pubmed">33306450</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiong &#xa0;T-Y, Redwood &#xa0;S, Prendergast &#xa0;B, Chen &#xa0;M. Coronaviruses and the cardiovascular system: acute and long-term implications. Eur Heart J &#xa0;2020;41:1798&#x2013;1800.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7454513</ArticleId><ArticleId IdType="pubmed">32186331</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang &#xa0;D, Hu &#xa0;B, Hu &#xa0;C, Zhu &#xa0;F, Liu &#xa0;X, Zhang &#xa0;J, et al. &#xa0;Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus&#x2013;infected pneumonia in Wuhan, China. JAMA &#xa0;2020;323:1061&#x2013;1069.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7042881</ArticleId><ArticleId IdType="pubmed">32031570</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi &#xa0;S, Qin &#xa0;M, Shen &#xa0;B, Cai &#xa0;Y, Liu &#xa0;T, Yang &#xa0;F, et al. &#xa0;Association of cardiac injury with mortality in hospitalized patients with COVID-19 in Wuhan, China. JAMA Cardiol &#xa0;2020;5:802&#x2013;810.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7097841</ArticleId><ArticleId IdType="pubmed">32211816</ArticleId></ArticleIdList></Reference><Reference><Citation>Lala &#xa0;A, Johnson &#xa0;KW, Januzzi &#xa0;JL, Russak &#xa0;AJ, Paranjpe &#xa0;I, Richter &#xa0;F, et al. &#xa0;Prevalence and impact of myocardial injury in patients hospitalized with COVID-19 infection. J Am Coll Cardiol &#xa0;2020;76:533&#x2013;546.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7279721</ArticleId><ArticleId IdType="pubmed">32517963</ArticleId></ArticleIdList></Reference><Reference><Citation>Lombardi &#xa0;CM, Carubelli &#xa0;V, Iorio &#xa0;A, Inciardi &#xa0;RM, Bellasi &#xa0;A, Canale &#xa0;C, et al. &#xa0;Association of troponin levels with mortality in Italian patients hospitalized with coronavirus disease 2019: results of a multicenter study. JAMA Cardiol &#xa0;2020;5:1274&#x2013;1280.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7450398</ArticleId><ArticleId IdType="pubmed">32845276</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi &#xa0;S, Qin &#xa0;M, Cai &#xa0;Y, Liu &#xa0;T, Shen &#xa0;B, Yang &#xa0;F, et al. &#xa0;Characteristics and clinical significance of myocardial injury in patients with severe coronavirus disease 2019. Eur Heart J &#xa0;2020;41:2070&#x2013;2079.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7239100</ArticleId><ArticleId IdType="pubmed">32391877</ArticleId></ArticleIdList></Reference><Reference><Citation>Ayoubkhani &#xa0;D, Khunti &#xa0;K, Nafilyan &#xa0;V, Maddox &#xa0;T, Humberstone &#xa0;B, Diamond &#xa0;I, et al. &#xa0;Post-COVID syndrome in individuals admitted to hospital with COVID-19: retrospective cohort study. BMJ &#xa0;2021;372:n693.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8010267</ArticleId><ArticleId IdType="pubmed">33789877</ArticleId></ArticleIdList></Reference><Reference><Citation>Daugherty &#xa0;SE, Guo &#xa0;Y, Heath &#xa0;K, Dasmari&#xf1;as &#xa0;MC, Jubilo &#xa0;KG, Samranvedhya &#xa0;J, et al. &#xa0;Risk of clinical sequelae after the acute phase of SARS-CoV-2 infection: retrospective cohort study. BMJ &#xa0;2021;373:n1098.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8132065</ArticleId><ArticleId IdType="pubmed">34011492</ArticleId></ArticleIdList></Reference><Reference><Citation>Tazare &#xa0;J, Walker &#xa0;AJ, Tomlinson &#xa0;L, Hickman &#xa0;G, Rentsch &#xa0;CT, Williamson &#xa0;EJ, et al. &#xa0;Rates of serious clinical outcomes in survivors of hospitalisation with COVID-19: a descriptive cohort study within the OpenSAFELY platform. MedRxiv &#xa0;2021. doi: 10.1101/2021.01.22.21250304</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2021.01.22.21250304</ArticleId><ArticleId IdType="pmc">PMC10285340</ArticleId><ArticleId IdType="pubmed">37362009</ArticleId></ArticleIdList></Reference><Reference><Citation>Kotecha &#xa0;T, Knight &#xa0;DS, Razvi &#xa0;Y, Kumar &#xa0;K, Vimalesvaran &#xa0;K, Thornton &#xa0;G, et al. &#xa0;Patterns of myocardial injury in recovered troponin-positive COVID-19 patients assessed by cardiovascular magnetic resonance. Eur Heart J &#xa0;2021;42:1866&#x2013;1878.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7928984</ArticleId><ArticleId IdType="pubmed">33596594</ArticleId></ArticleIdList></Reference><Reference><Citation>Clavario &#xa0;P, De Marzo &#xa0;V, Lotti &#xa0;R, Barbara &#xa0;C, Porcile &#xa0;A, Russo &#xa0;C, et al. &#xa0;Assessment of functional capacity with cardiopulmonary exercise testing in non-severe COVID-19 patients at three months follow-up. MedRxiv &#xa0;2020. doi:10.1101/2020.11.15.20231985</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2020.11.15.20231985</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma&#x142;ek &#xa0;&#x141;A, Marczak &#xa0;M, Mi&#x142;osz-Wieczorek &#xa0;B, Konopka &#xa0;M, Braksator &#xa0;W, Drygas &#xa0;W, et al. &#xa0;Cardiac involvement in consecutive elite athletes recovered from Covid-19: a magnetic resonance study. J Magn Reson Imaging &#xa0;2021;53:1723&#x2013;1729.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8014772</ArticleId><ArticleId IdType="pubmed">33474768</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang &#xa0;H, Li &#xa0;R, Zhou &#xa0;Z, Jiang &#xa0;H, Yan &#xa0;Z, Tao &#xa0;X, et al. &#xa0;Cardiac involvement in COVID-19 patients: mid-term follow up by cardiovascular magnetic resonance. J Cardiovasc Magn Reson &#xa0;2021;23:14.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7904320</ArticleId><ArticleId IdType="pubmed">33627143</ArticleId></ArticleIdList></Reference><Reference><Citation>Vago &#xa0;H, Szabo &#xa0;L, Dohy &#xa0;Z, Merkely &#xa0;B. Cardiac magnetic resonance findings in patients recovered from COVID-19: initial experiences in elite athletes. Cardiovasc Imaging &#xa0;2021;14:1279&#x2013;1281.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7837171</ArticleId><ArticleId IdType="pubmed">33341416</ArticleId></ArticleIdList></Reference><Reference><Citation>Mohr &#xa0;A, Dannerbeck &#xa0;L, Lange &#xa0;TJ, Pfeifer &#xa0;M, Blaas &#xa0;S, Salzberger &#xa0;B, et al. &#xa0;Cardiopulmonary exercise pattern in patients with persistent dyspnoea after recovery from COVID-19. Multidiscip Respir Med &#xa0;2021;16:732.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7893311</ArticleId><ArticleId IdType="pubmed">33623700</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao &#xa0;Y, Chen &#xa0;R, Geng &#xa0;Q, Mo &#xa0;X, Zhan &#xa0;C, Jian &#xa0;W, et al. &#xa0;Cardiopulmonary exercise testing might be helpful for interpretation of impaired pulmonary function in recovered COVID-19 patients. Eur Respir J &#xa0;2021;57:2004265.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7758779</ArticleId><ArticleId IdType="pubmed">33361097</ArticleId></ArticleIdList></Reference><Reference><Citation>Debeaumont &#xa0;D, Boujibar &#xa0;F, Ferrand-Devouge &#xa0;E, Artaud-Macari &#xa0;E, Tamion &#xa0;F, Gravier &#xa0;FE, et al. &#xa0;Cardiopulmonary exercise testing to assess persistent symptoms at 6 months in people with COVID-19 who survived hospitalization: a pilot study. Phys Ther &#xa0;2021;101:pzab099.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7989156</ArticleId><ArticleId IdType="pubmed">33735374</ArticleId></ArticleIdList></Reference><Reference><Citation>Sonnweber &#xa0;T, Sahanic &#xa0;S, Pizzini &#xa0;A, Luger &#xa0;A, Schwabl &#xa0;C, Sonnweber &#xa0;B, et al. &#xa0;Cardiopulmonary recovery after COVID-19: an observational prospective multicentre trial. Eur Respir J &#xa0;2021;57:2003481.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7736754</ArticleId><ArticleId IdType="pubmed">33303539</ArticleId></ArticleIdList></Reference><Reference><Citation>Hendrickson &#xa0;BS, Stephens &#xa0;RE, Chang &#xa0;JV, Amburn &#xa0;JM, Pierotti &#xa0;LL, Johnson &#xa0;JL, et al. &#xa0;Cardiovascular evaluation after COVID-19 in 137 collegiate athletes: results of an algorithm-guided screening. Circulation &#xa0;2021;143:1926&#x2013;1928.</Citation><ArticleIdList><ArticleId IdType="pubmed">33970675</ArticleId></ArticleIdList></Reference><Reference><Citation>Rajpal &#xa0;S, Tong &#xa0;MS, Borchers &#xa0;J, Zareba &#xa0;KM, Obarski &#xa0;TP, Simonetti &#xa0;OP, et al. &#xa0;Cardiovascular magnetic resonance findings in competitive athletes recovering from COVID-19 infection. JAMA Cardiol &#xa0;2021;6:116&#x2013;118.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7489396</ArticleId><ArticleId IdType="pubmed">32915194</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou &#xa0;M, Wong &#xa0;C-K, Un &#xa0;K-C, Lau &#xa0;Y-M, Lee &#xa0;JC-Y, Tam &#xa0;FC-C, et al. &#xa0;Cardiovascular sequalae in uncomplicated COVID-19 survivors. PLoS One &#xa0;2021;16:e0246732.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7877588</ArticleId><ArticleId IdType="pubmed">33571321</ArticleId></ArticleIdList></Reference><Reference><Citation>Clark &#xa0;DE, Parikh &#xa0;A, Dendy &#xa0;JM, Diamond &#xa0;AB, George-Durrett &#xa0;K, Fish &#xa0;FA, et al. &#xa0;COVID-19 myocardial pathology evaluation in athletes with cardiac magnetic resonance (COMPETE CMR). Circulation &#xa0;2021;143:609&#x2013;612.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7864610</ArticleId><ArticleId IdType="pubmed">33332151</ArticleId></ArticleIdList></Reference><Reference><Citation>Knight &#xa0;DS, Kotecha &#xa0;T, Razvi &#xa0;Y, Chacko &#xa0;L, Brown &#xa0;JT, Jeetley &#xa0;PS, et al. &#xa0;COVID-19: myocardial injury in survivors. Circulation &#xa0;2020;142:1120&#x2013;1122.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7492396</ArticleId><ArticleId IdType="pubmed">32673505</ArticleId></ArticleIdList></Reference><Reference><Citation>Rinaldo &#xa0;RF, Mondoni &#xa0;M, Parazzini &#xa0;EM, Pitari &#xa0;F, Brambilla &#xa0;E, Luraschi &#xa0;S, et al. &#xa0;Deconditioning as main mechanism of impaired exercise response in COVID-19 survivors. Eur Respir J &#xa0;2021;58:2100870.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8082950</ArticleId><ArticleId IdType="pubmed">33926969</ArticleId></ArticleIdList></Reference><Reference><Citation>Catena &#xa0;C, Colussi &#xa0;G, Bulfone &#xa0;L, Da Porto &#xa0;A, Tascini &#xa0;C, Sechi &#xa0;LA. Echocardiographic comparison of COVID-19 patients with or without prior biochemical evidence of cardiac injury after recovery. J Am Soc Echocardiogr &#xa0;2021;34:193&#x2013;195.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7580530</ArticleId><ArticleId IdType="pubmed">33243582</ArticleId></ArticleIdList></Reference><Reference><Citation>Starekova &#xa0;J, Bluemke &#xa0;DA, Bradham &#xa0;WS, Eckhardt &#xa0;LL, Grist &#xa0;TM, Kusmirek &#xa0;JE, et al. &#xa0;Evaluation for myocarditis in competitive student athletes recovering from coronavirus disease 2019 with cardiac magnetic resonance imaging. JAMA Cardiol &#xa0;2021;6:945&#x2013;950.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7809616</ArticleId><ArticleId IdType="pubmed">33443537</ArticleId></ArticleIdList></Reference><Reference><Citation>Motiejunaite &#xa0;J, Balagny &#xa0;P, Arnoult &#xa0;F, Mangin &#xa0;L, Bancal &#xa0;C, d&#x2019;Ortho &#xa0;M-P, et al. &#xa0;Hyperventilation: a possible explanation for long-lasting exercise intolerance in mild Covid-19 survivors? &#xa0;Front Physiol &#xa0;2021;11:1856.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7849606</ArticleId><ArticleId IdType="pubmed">33536937</ArticleId></ArticleIdList></Reference><Reference><Citation>Baratto &#xa0;C, Caravita &#xa0;S, Faini &#xa0;A, Perego &#xa0;GB, Senni &#xa0;M, Badano &#xa0;LP, et al. &#xa0;Impact of COVID-19 on exercise pathophysiology: a combined cardiopulmonary and echocardiographic exercise study. J Appl Physiol &#xa0;2021;130:1470&#x2013;1478.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8143785</ArticleId><ArticleId IdType="pubmed">33764166</ArticleId></ArticleIdList></Reference><Reference><Citation>Raman &#xa0;B, Cassar &#xa0;MP, Tunnicliffe &#xa0;EM, Filippini &#xa0;N, Griffanti &#xa0;L, Alfaro-Almagro &#xa0;F, et al. &#xa0;Medium-term effects of SARS-CoV-2 infection on multiple vital organs, exercise capacity, cognition, quality of life and mental health, post-hospital discharge. EClinicalMedicine &#xa0;2021;31:100683.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7808914</ArticleId><ArticleId IdType="pubmed">33490928</ArticleId></ArticleIdList></Reference><Reference><Citation>Dennis &#xa0;A, Wamil &#xa0;M, Alberts &#xa0;J, Oben &#xa0;J, Cuthbertson &#xa0;DJ, Wootton &#xa0;D, et al. &#xa0;Multiorgan impairment in low-risk individuals with post-COVID-19 syndrome: a prospective, community-based study. BMJ Open &#xa0;2021;11:e048391.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8727683</ArticleId><ArticleId IdType="pubmed">33785495</ArticleId></ArticleIdList></Reference><Reference><Citation>Puntmann &#xa0;VO, Carerj &#xa0;ML, Wieters &#xa0;I, Fahim &#xa0;M, Arendt &#xa0;C, Hoffmann &#xa0;J, et al. &#xa0;Outcomes of cardiovascular magnetic resonance imaging in patients recently recovered from coronavirus disease 2019 (COVID-19). JAMA Cardiol &#xa0;2020;5:1265&#x2013;1273.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7385689</ArticleId><ArticleId IdType="pubmed">32730619</ArticleId></ArticleIdList></Reference><Reference><Citation>Ng &#xa0;MY, Ferreira &#xa0;VM, Leung &#xa0;ST, Lee &#xa0;JCY, Fong &#xa0;AHT, Liu &#xa0;RWT, et al. &#xa0;Patients recovered from COVID-19 show ongoing subclinical myocarditis as revealed by cardiac magnetic resonance imaging. JACC Cardiovasc Imaging &#xa0;2020;13:2476&#x2013;2478.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7455163</ArticleId><ArticleId IdType="pubmed">33153536</ArticleId></ArticleIdList></Reference><Reference><Citation>Eiros &#xa0;R, Barreiro-Perez &#xa0;M, Martin-Garcia &#xa0;A, Almeida &#xa0;J, Villacorta &#xa0;E, Perez-Pons &#xa0;A, et al. &#xa0;Pericarditis and myocarditis long after SARS-CoV-2 infection: a cross-sectional descriptive study in health-care workers. MedRxiv &#xa0;2020. doi: 10.1101/2020.07.12.20151316</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2020.07.12.20151316</ArticleId></ArticleIdList></Reference><Reference><Citation>Moody &#xa0;WE, Liu &#xa0;B, Mahmoud-Elsayed &#xa0;HM, Senior &#xa0;J, Lalla &#xa0;SS, Khan-Kheil &#xa0;AM, et al. &#xa0;Persisting adverse ventricular remodeling in COVID-19 survivors: a longitudinal echocardiographic study. J Am Soc Echocardiogr &#xa0;2021;34:562&#x2013;566.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8008825</ArticleId><ArticleId IdType="pubmed">33539950</ArticleId></ArticleIdList></Reference><Reference><Citation>Daniels &#xa0;CJ, Rajpal &#xa0;S, Greenshields &#xa0;JT, Rosenthal &#xa0;GL, Chung &#xa0;EH, Terrin &#xa0;M, et al. &#xa0;Prevalence of clinical and subclinical myocarditis in competitive athletes with recent SARS-CoV-2 infection: results from the big ten COVID-19 cardiac registry. JAMA Cardiol &#xa0;2021;6:1078&#x2013;1087.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8160916</ArticleId><ArticleId IdType="pubmed">34042947</ArticleId></ArticleIdList></Reference><Reference><Citation>Martinez &#xa0;MW, Tucker &#xa0;AM, Bloom &#xa0;OJ, Green &#xa0;G, DiFiori &#xa0;JP, Solomon &#xa0;G, et al. &#xa0;Prevalence of inflammatory heart disease among professional athletes with prior COVID-19 infection who received systematic return-to-play cardiac screening. JAMA Cardiol &#xa0;2021;6:745&#x2013;752.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7934073</ArticleId><ArticleId IdType="pubmed">33662103</ArticleId></ArticleIdList></Reference><Reference><Citation>Joy &#xa0;G, Artico &#xa0;J, Kurdi &#xa0;H, Seraphim &#xa0;A, Lau &#xa0;C, Thornton &#xa0;GD, et al. &#xa0;Prospective case&#x2013;control study of cardiovascular abnormalities 6 months following mild COVID-19 in healthcare workers. JACC Cardiovasc Imaging &#xa0;2021;14:2155&#x2013;2166.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8105493</ArticleId><ArticleId IdType="pubmed">33975819</ArticleId></ArticleIdList></Reference><Reference><Citation>Moulson &#xa0;N, Petek &#xa0;BJ, Drezner &#xa0;JA, Harmon &#xa0;KG, Kliethermes &#xa0;SA, Patel &#xa0;MR, et al. &#xa0;SARS-CoV-2 cardiac involvement in young competitive athletes. Circulation &#xa0;2021;144:256&#x2013;266.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8300154</ArticleId><ArticleId IdType="pubmed">33866822</ArticleId></ArticleIdList></Reference><Reference><Citation>Sechi &#xa0;LA, Colussi &#xa0;G, Bulfone &#xa0;L, Brosolo &#xa0;G, Da Porto &#xa0;A, Peghin &#xa0;M, et al. &#xa0;Short-term cardiac outcome in survivors of COVID-19: a systematic study after hospital discharge. Clin Res Cardiol &#xa0;2021;110:1063&#x2013;1072.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7820534</ArticleId><ArticleId IdType="pubmed">33481096</ArticleId></ArticleIdList></Reference><Reference><Citation>de Graaf &#xa0;M, Antoni &#xa0;M, Ter Kuile &#xa0;M, Arbous &#xa0;M, Duinisveld &#xa0;A, Feltkamp &#xa0;M, et al. &#xa0;Short-term outpatient follow-up of COVID-19 patients: a multidisciplinary approach. EClinicalMedicine &#xa0;2021;32:100731.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7843037</ArticleId><ArticleId IdType="pubmed">33532720</ArticleId></ArticleIdList></Reference><Reference><Citation>Daher &#xa0;A, Cornelissen &#xa0;C, Hartmann &#xa0;N-U, Balfanz &#xa0;P, M&#xfc;ller &#xa0;A, Bergs &#xa0;I, et al. &#xa0;Six months follow-up of patients with invasive mechanical ventilation due to COVID-19 related ARDS. Int J Environ Res Public Health &#xa0;2021;18:5861.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8199360</ArticleId><ArticleId IdType="pubmed">34072557</ArticleId></ArticleIdList></Reference><Reference><Citation>Myhre &#xa0;PL, Heck &#xa0;SL, Skranes &#xa0;JB, Prebensen &#xa0;C, Jonassen &#xa0;CM, Berge &#xa0;T, et al. &#xa0;Cardiac pathology 6 months after hospitalization for COVID-19 and association with the acute disease severity: cardiac MRI 6 months after COVID-19. Am Heart J &#xa0;2021;242:61&#x2013;70.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8363180</ArticleId><ArticleId IdType="pubmed">34400140</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang &#xa0;L, Zhao &#xa0;P, Tang &#xa0;D, Zhu &#xa0;T, Han &#xa0;R, Zhan &#xa0;C, et al. &#xa0;Cardiac involvement in patients recovered from COVID-2019 identified using magnetic resonance imaging. JACC Cardiovasc Imaging &#xa0;2020;13:2330&#x2013;2339.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7214335</ArticleId><ArticleId IdType="pubmed">32763118</ArticleId></ArticleIdList></Reference><Reference><Citation>Hall &#xa0;J, Myall &#xa0;K, Lam &#xa0;JL, Mason &#xa0;T, Mukherjee &#xa0;B, West &#xa0;A, et al. &#xa0;Identifying patients at risk of post-discharge complications related to COVID-19 infection. Thorax &#xa0;2021;76:408&#x2013;411.</Citation><ArticleIdList><ArticleId IdType="pubmed">33542090</ArticleId></ArticleIdList></Reference><Reference><Citation>Li &#xa0;X, Wang &#xa0;H, Zhao &#xa0;R, Wang &#xa0;T, Zhu &#xa0;Y, Qian &#xa0;Y, et al. &#xa0;Elevated extracellular volume fraction and reduced global longitudinal strains in patients recovered from COVID-19 without clinical cardiac findings. Radiology &#xa0;2021;299:E230&#x2013;E240.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7808090</ArticleId><ArticleId IdType="pubmed">33434112</ArticleId></ArticleIdList></Reference><Reference><Citation>Long &#xa0;B, Brady &#xa0;WJ, Bridwell &#xa0;RE, Ramzy &#xa0;M, Montrief &#xa0;T, Singh &#xa0;M, et al. &#xa0;Electrocardiographic manifestations of COVID-19. Am J Emerg Med &#xa0;2021;41:96&#x2013;103.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7771377</ArticleId><ArticleId IdType="pubmed">33412365</ArticleId></ArticleIdList></Reference><Reference><Citation>Desai &#xa0;AD, Boursiquot &#xa0;BC, Melki &#xa0;L, Wan &#xa0;EY. Management of arrhythmias associated with COVID-19. Curr Cardiol Rep &#xa0;2021;23:2.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7685181</ArticleId><ArticleId IdType="pubmed">33231782</ArticleId></ArticleIdList></Reference><Reference><Citation>Radin &#xa0;JM, Quer &#xa0;G, Ramos &#xa0;E, Baca-Motes &#xa0;K, Gadaleta &#xa0;M, Topol &#xa0;EJ, et al. &#xa0;Assessment of prolonged physiological and behavioral changes associated with COVID-19 infection. JAMA Network Open &#xa0;2021;4:e2115959.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8264646</ArticleId><ArticleId IdType="pubmed">34232306</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang &#xa0;TY, Chao &#xa0;TF, Liu &#xa0;CJ, Chen &#xa0;SJ, Chung &#xa0;FP, Liao &#xa0;JN, et al. &#xa0;The association between influenza infection, vaccination, and atrial fibrillation: a nationwide case-control study. Heart Rhythm &#xa0;2016;13:1189&#x2013;1194.</Citation><ArticleIdList><ArticleId IdType="pubmed">26850784</ArticleId></ArticleIdList></Reference><Reference><Citation>Chung &#xa0;MK, Martin &#xa0;DO, Sprecher &#xa0;D, Wazni &#xa0;O, Kanderian &#xa0;A, Carnes &#xa0;CA, et al. &#xa0;C-reactive protein elevation in patients with atrial arrhythmias: inflammatory mechanisms and persistence of atrial fibrillation. Circulation &#xa0;2001;104:2886&#x2013;2891.</Citation><ArticleIdList><ArticleId IdType="pubmed">11739301</ArticleId></ArticleIdList></Reference><Reference><Citation>Lakin &#xa0;R, Polidovitch &#xa0;N, Yang &#xa0;S, Guzman &#xa0;C, Gao &#xa0;X, Wauchop &#xa0;M, et al. &#xa0;Inhibition of soluble TNF&#x3b1; prevents adverse atrial remodeling and atrial arrhythmia susceptibility induced in mice by endurance exercise. J Mol Cell Cardiol &#xa0;2019;129:165&#x2013;173.</Citation><ArticleIdList><ArticleId IdType="pubmed">30796945</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu &#xa0;YF, Chen &#xa0;YJ, Lin &#xa0;YJ, Chen &#xa0;SA. Inflammation and the pathogenesis of atrial fibrillation. Nat Rev Cardiol &#xa0;2015;12:230&#x2013;243.</Citation><ArticleIdList><ArticleId IdType="pubmed">25622848</ArticleId></ArticleIdList></Reference><Reference><Citation>Liuba &#xa0;I, Ahlmroth &#xa0;H, Jonasson &#xa0;L, Englund &#xa0;A, J&#xf6;nsson &#xa0;A, S&#xe4;fstr&#xf6;m &#xa0;K, et al. &#xa0;Source of inflammatory markers in patients with atrial fibrillation. Europace &#xa0;2008;10:848&#x2013;853.</Citation><ArticleIdList><ArticleId IdType="pubmed">18523031</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen &#xa0;Y, Wu &#xa0;S, Li &#xa0;W, Wang &#xa0;B, Han &#xa0;X, Yang &#xa0;Y, et al. &#xa0;Higher high-sensitivity c reactive protein is associated with future premature ventricular contraction: a community based prospective cohort study. Sci Rep &#xa0;2018;8:5152.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5979945</ArticleId><ArticleId IdType="pubmed">29581482</ArticleId></ArticleIdList></Reference><Reference><Citation>Flachskampf &#xa0;FA, Biering-S&#xf8;rensen &#xa0;T, Solomon &#xa0;SD, Duvernoy &#xa0;O, Bjerner &#xa0;T, Smiseth &#xa0;OA. Cardiac imaging to evaluate left ventricular diastolic function. JACC Cardiovasc Imaging &#xa0;2015;8:1071&#x2013;1093.</Citation><ArticleIdList><ArticleId IdType="pubmed">26381769</ArticleId></ArticleIdList></Reference><Reference><Citation>Pennell &#xa0;DJ. Cardiovascular magnetic resonance. Circulation &#xa0;2010;121:692&#x2013;705.</Citation><ArticleIdList><ArticleId IdType="pubmed">20142462</ArticleId></ArticleIdList></Reference><Reference><Citation>Bozkurt &#xa0;B, Colvin &#xa0;M, Cook &#xa0;J, Cooper &#xa0;LT, Deswal &#xa0;A, Fonarow &#xa0;GC, et al. &#xa0;Current diagnostic and treatment strategies for specific dilated cardiomyopathies: a scientific statement from the American Heart Association. Circulation &#xa0;2016;134:e579&#x2013;e646.</Citation><ArticleIdList><ArticleId IdType="pubmed">27832612</ArticleId></ArticleIdList></Reference><Reference><Citation>Ammirati &#xa0;E, Frigerio &#xa0;M, Adler &#xa0;ED, Basso &#xa0;C, Birnie &#xa0;DH, Brambatti &#xa0;M, et al. &#xa0;Management of acute myocarditis and chronic inflammatory cardiomyopathy: an expert consensus document. Circ Heart Fail &#xa0;2020;13:e007405.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7673642</ArticleId><ArticleId IdType="pubmed">33176455</ArticleId></ArticleIdList></Reference><Reference><Citation>Caforio &#xa0;AL, Pankuweit &#xa0;S, Arbustini &#xa0;E, Basso &#xa0;C, Gimeno-Blanes &#xa0;J, Felix &#xa0;SB, et al. &#xa0;Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur Heart J &#xa0;2013;34:2636&#x2013;2648.</Citation><ArticleIdList><ArticleId IdType="pubmed">23824828</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferreira &#xa0;VM, Schulz-Menger &#xa0;J, Holmvang &#xa0;G, Kramer &#xa0;CM, Carbone &#xa0;I, Sechtem &#xa0;U, et al. &#xa0;Cardiovascular magnetic resonance in nonischemic myocardial inflammation: expert recommendations. J Am Coll Cardiol &#xa0;2018;72:3158&#x2013;3176.</Citation><ArticleIdList><ArticleId IdType="pubmed">30545455</ArticleId></ArticleIdList></Reference><Reference><Citation>Hinojar &#xa0;R, Varma &#xa0;N, Child &#xa0;N, Goodman &#xa0;B, Jabbour &#xa0;A, Yu &#xa0;CY, et al. &#xa0;T1 mapping in discrimination of hypertrophic phenotypes: hypertensive heart disease and hypertrophic cardiomyopathy: findings from the international T1 multicenter cardiovascular magnetic resonance study. Circ Cardiovasc Imaging &#xa0;2015;8:e003285.</Citation><ArticleIdList><ArticleId IdType="pubmed">26659373</ArticleId></ArticleIdList></Reference><Reference><Citation>Ridouani &#xa0;F, Damy &#xa0;T, Tacher &#xa0;V, Derbel &#xa0;H, Legou &#xa0;F, Sifaoui &#xa0;I, et al. &#xa0;Myocardial native T2 measurement to differentiate light-chain and transthyretin cardiac amyloidosis and assess prognosis. J Cardiovasc Magn Reson &#xa0;2018;20:58.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6097442</ArticleId><ArticleId IdType="pubmed">30115079</ArticleId></ArticleIdList></Reference><Reference><Citation>Schulz-Menger &#xa0;J, Bluemke &#xa0;DA, Bremerich &#xa0;J, Flamm &#xa0;SD, Fogel &#xa0;MA, Friedrich &#xa0;MG, et al. &#xa0;Standardized image interpretation and post processing in cardiovascular magnetic resonance: Society for Cardiovascular Magnetic Resonance (SCMR) board of trustees task force on standardized post processing. J Cardiovasc Magn Reson &#xa0;2013;15:1&#x2013;19.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3695769</ArticleId><ArticleId IdType="pubmed">23634753</ArticleId></ArticleIdList></Reference><Reference><Citation>Bai &#xa0;W, Raman &#xa0;B, Petersen &#xa0;SE, Neubauer &#xa0;S, Raisi-Estabragh &#xa0;Z, Aung &#xa0;N, et al. &#xa0;Longitudinal changes of cardiac and aortic imaging phenotypes following COVID-19 in the UK biobank cohort. medRxiv &#xa0;2021. doi:10.1101/2021.11.04.21265918</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2021.11.04.21265918</ArticleId></ArticleIdList></Reference><Reference><Citation>Pathik &#xa0;B, Raman &#xa0;B, Mohd Amin &#xa0;NH, Mahadavan &#xa0;D, Rajendran &#xa0;S, McGavigan &#xa0;AD, et al. &#xa0;Troponin-positive chest pain with unobstructed coronary arteries: incremental diagnostic value of cardiovascular magnetic resonance imaging. Eur Heart J Cardiovasc Imaging &#xa0;2016;17:1146&#x2013;1152.</Citation><ArticleIdList><ArticleId IdType="pubmed">26590396</ArticleId></ArticleIdList></Reference><Reference><Citation>Dastidar &#xa0;AG, Baritussio &#xa0;A, De Garate &#xa0;E, Drobni &#xa0;Z, Biglino &#xa0;G, Singhal &#xa0;P, et al. &#xa0;Prognostic role of CMR and conventional risk factors in myocardial infarction with nonobstructed coronary arteries. JACC Cardiovasc Imaging &#xa0;2019;12:1973&#x2013;1982.</Citation><ArticleIdList><ArticleId IdType="pubmed">30772224</ArticleId></ArticleIdList></Reference><Reference><Citation>Assomull &#xa0;RG, Lyne &#xa0;JC, Keenan &#xa0;N, Gulati &#xa0;A, Bunce &#xa0;NH, Davies &#xa0;SW, et al. &#xa0;The role of cardiovascular magnetic resonance in patients presenting with chest pain, raised troponin, and unobstructed coronary arteries. Eur Heart J &#xa0;2007;28:1242&#x2013;1249.</Citation><ArticleIdList><ArticleId IdType="pubmed">17478458</ArticleId></ArticleIdList></Reference><Reference><Citation>Dweck &#xa0;MR, Bularga &#xa0;A, Hahn &#xa0;RT, Bing &#xa0;R, Lee &#xa0;KK, Chapman &#xa0;AR, et al. &#xa0;Global evaluation of echocardiography in patients with COVID-19. Eur Heart J Cardiovasc Imaging &#xa0;2020;21:949&#x2013;958.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7337658</ArticleId><ArticleId IdType="pubmed">32556199</ArticleId></ArticleIdList></Reference><Reference><Citation>Argulian &#xa0;E, Sud &#xa0;K, Vogel &#xa0;B, Bohra &#xa0;C, Garg &#xa0;VP, Talebi &#xa0;S, et al. &#xa0;Right ventricular dilation in hospitalized patients with COVID-19 infection. JACC Cardiovasc Imaging &#xa0;2020;13:2459&#x2013;2461.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7228729</ArticleId><ArticleId IdType="pubmed">32426088</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim &#xa0;J, Volodarskiy &#xa0;A, Sultana &#xa0;R, Pollie &#xa0;MP, Yum &#xa0;B, Nambiar &#xa0;L, et al. &#xa0;Prognostic utility of right ventricular remodeling over conventional risk stratification in patients with COVID-19. J Am Coll Cardiol &#xa0;2020;76:1965&#x2013;1977.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7572068</ArticleId><ArticleId IdType="pubmed">33092732</ArticleId></ArticleIdList></Reference><Reference><Citation>Buikema &#xa0;JW, Asselbergs &#xa0;FW, Tekstra &#xa0;J. COVID-19 related thrombi in ascending and descending thoracic aorta with peripheral embolization: a case report. Eur Heart J Case Rep &#xa0;2021;5:ytaa525.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7859600</ArticleId><ArticleId IdType="pubmed">33569525</ArticleId></ArticleIdList></Reference><Reference><Citation>&#xc7;ora &#xa0;AR, &#xc7;elik &#xa0;E, Karadem &#xa0;KB. Aortic thrombosis in the course of Covid-19 disease; two rare cases. Ann Vasc Surg &#xa0;2021;73:119&#x2013;121.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7936762</ArticleId><ArticleId IdType="pubmed">33689757</ArticleId></ArticleIdList></Reference><Reference><Citation>de Carranza &#xa0;M, Salazar &#xa0;DE, Troya &#xa0;J, Alc&#xe1;zar &#xa0;R, Pe&#xf1;a &#xa0;C, Arag&#xf3;n &#xa0;E, et al. &#xa0;Aortic thrombus in patients with severe COVID-19: review of three cases. J Thromb Thrombolysis &#xa0;2021;51:237&#x2013;242.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7344037</ArticleId><ArticleId IdType="pubmed">32648092</ArticleId></ArticleIdList></Reference><Reference><Citation>Oikonomou &#xa0;EK, Marwan &#xa0;M, Desai &#xa0;MY, Mancio &#xa0;J, Alashi &#xa0;A, Hutt Centeno &#xa0;E, et al. &#xa0;Non-invasive detection of coronary inflammation using computed tomography and prediction of residual cardiovascular risk (the CRISP CT study): a post-hoc analysis of prospective outcome data. Lancet &#xa0;2018;392:929&#x2013;939.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6137540</ArticleId><ArticleId IdType="pubmed">30170852</ArticleId></ArticleIdList></Reference><Reference><Citation>Elnabawi &#xa0;YA, Oikonomou &#xa0;EK, Dey &#xa0;AK, Mancio &#xa0;J, Rodante &#xa0;JA, Aksentijevich &#xa0;M, et al. &#xa0;Association of biologic therapy with coronary inflammation in patients with psoriasis as assessed by perivascular fat attenuation index. JAMA Cardiol &#xa0;2019;4:885&#x2013;891.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6669789</ArticleId><ArticleId IdType="pubmed">31365032</ArticleId></ArticleIdList></Reference><Reference><Citation>Kotanidis &#xa0;CP, Xie &#xa0;C, Adlam &#xa0;D, Rodrigues &#xa0;JC, Siddique &#xa0;M, Lockstone &#xa0;H, et al. &#xa0;Radiotranscriptomic analysis of perivascular adipose tissue quantifies vascular inflammation in Covid-19 from routine CT angiograms: stratification of &#x201c;new UK variant&#x201d; infection and prediction of in-hospital outcomes [abstract]. Heart &#xa0;2021;107:A177.</Citation></Reference><Reference><Citation>Fan &#xa0;BE, Umapathi &#xa0;T, Chua &#xa0;K, Chia &#xa0;YW, Wong &#xa0;SW, Tan &#xa0;GWL, et al. &#xa0;Delayed catastrophic thrombotic events in young and asymptomatic post COVID-19 patients. J Thromb Thrombolysis &#xa0;2021;51:971&#x2013;977.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7648538</ArticleId><ArticleId IdType="pubmed">33159640</ArticleId></ArticleIdList></Reference><Reference><Citation>Patell &#xa0;R, Bogue &#xa0;T, Koshy &#xa0;A, Bindal &#xa0;P, Merrill &#xa0;M, Aird &#xa0;WC, et al. &#xa0;Postdischarge thrombosis and hemorrhage in patients with COVID-19. Blood &#xa0;2020;136:1342&#x2013;1346.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7483433</ArticleId><ArticleId IdType="pubmed">32766883</ArticleId></ArticleIdList></Reference><Reference><Citation>Engelen &#xa0;M, Vanassche &#xa0;T, Balthazar &#xa0;T, Claeys &#xa0;E, Gunst &#xa0;J, Jacquemin &#xa0;M, et al. &#xa0;Incidence of venous thromboembolism in patients discharged after COVID-19 hospitalisation [abstract]. Res Pract Thromb Haemost &#xa0;2020;4:CO01.3.</Citation><ArticleIdList><ArticleId IdType="pubmed">0</ArticleId></ArticleIdList></Reference><Reference><Citation>Remy-Jardin &#xa0;M, Duthoit &#xa0;L, Perez &#xa0;T, Felloni &#xa0;P, Faivre &#xa0;JB, Fry &#xa0;S, et al. &#xa0;Assessment of pulmonary arterial circulation 3 months after hospitalization for SARS-CoV-2 pneumonia: dual-energy CT (DECT) angiographic study in 55 patients. EClinicalMedicine &#xa0;2021;34:100778.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8008988</ArticleId><ArticleId IdType="pubmed">33817609</ArticleId></ArticleIdList></Reference><Reference><Citation>Donna M &#xa0;M, Danielle L &#xa0;B, Lala &#xa0;A, Trivieri Maria &#xa0;G, Contreras Johanna &#xa0;P, Natelson Benjamin &#xa0;H. Use of cardiopulmonary stress testing for patients with unexplained dyspnea post-coronavirus disease. JACC Heart Fail &#xa0;2021;9:927&#x2013;937.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8629098</ArticleId><ArticleId IdType="pubmed">34857177</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh &#xa0;I, Joseph &#xa0;P, Heerdt &#xa0;PM, Cullinan &#xa0;M, Lutchmansingh &#xa0;DD, Gulati &#xa0;M, et al. &#xa0;Persistent exertional intolerance after COVID-19: insights from invasive cardiopulmonary exercise testing. Chest &#xa0;2021. doi: 10.1016/j.chest.2021.08.010</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chest.2021.08.010</ArticleId><ArticleId IdType="pmc">PMC8354807</ArticleId><ArticleId IdType="pubmed">34389297</ArticleId></ArticleIdList></Reference><Reference><Citation>Di Filippo &#xa0;L, De Lorenzo &#xa0;R, D&#x2019;Amico &#xa0;M, Sofia &#xa0;V, Roveri &#xa0;L, Mele &#xa0;R, et al. &#xa0;COVID-19 is associated with clinically significant weight loss and risk of malnutrition, independent of hospitalisation: a post-hoc analysis of a prospective cohort study. Clin Nutr &#xa0;2021;40:2420&#x2013;2426.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7598735</ArticleId><ArticleId IdType="pubmed">33160700</ArticleId></ArticleIdList></Reference><Reference><Citation>Morley &#xa0;JE, Kalantar-Zadeh &#xa0;K, Anker &#xa0;SD. COVID-19: a major cause of cachexia and sarcopenia? &#xa0;J Cachexia Sarcopenia Muscle &#xa0;2020;11:863&#x2013;865.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7300782</ArticleId><ArticleId IdType="pubmed">32519505</ArticleId></ArticleIdList></Reference><Reference><Citation>Dorelli &#xa0;G, Braggio &#xa0;M, Gabbiani &#xa0;D, Busti &#xa0;F, Caminati &#xa0;M, Senna &#xa0;G, et al. &#xa0;Importance of cardiopulmonary exercise testing amongst subjects recovering from COVID-19. Diagnostics &#xa0;2021;11:507.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7998697</ArticleId><ArticleId IdType="pubmed">33809260</ArticleId></ArticleIdList></Reference><Reference><Citation>Johansson &#xa0;M, St&#xe5;hlberg &#xa0;M, Runold &#xa0;M, Nygren-Bonnier &#xa0;M, Nilsson &#xa0;J, Olshansky &#xa0;B, et al. &#xa0;Long-Haul post-COVID-19 symptoms presenting as a variant of postural orthostatic tachycardia syndrome: the Swedish experience. JACC Case Rep &#xa0;2021;3:573&#x2013;580.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7946344</ArticleId><ArticleId IdType="pubmed">33723532</ArticleId></ArticleIdList></Reference><Reference><Citation>Dani &#xa0;M, Dirksen &#xa0;A, Taraborrelli &#xa0;P, Torocastro &#xa0;M, Panagopoulos &#xa0;D, Sutton &#xa0;R, et al. &#xa0;Autonomic dysfunction in &#x2018;long COVID&#x2019;: rationale, physiology and management strategies. Clin Med &#xa0;2021;21:e63.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7850225</ArticleId><ArticleId IdType="pubmed">33243837</ArticleId></ArticleIdList></Reference><Reference><Citation>Kanjwal &#xa0;K, Jamal &#xa0;S, Kichloo &#xa0;A, Grubb &#xa0;BP. New-onset postural orthostatic tachycardia syndrome following coronavirus disease 2019 infection. J Innov Card Rhythm Manag &#xa0;2020;11:4302&#x2013;4304.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7685310</ArticleId><ArticleId IdType="pubmed">33262898</ArticleId></ArticleIdList></Reference><Reference><Citation>Miglis &#xa0;MG, Prieto &#xa0;T, Shaik &#xa0;R, Muppidi &#xa0;S, Sinn &#xa0;DI, Jaradeh &#xa0;S. A case report of postural tachycardia syndrome after COVID-19. Clin Auton Res &#xa0;2020;30:449&#x2013;451.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7471493</ArticleId><ArticleId IdType="pubmed">32880754</ArticleId></ArticleIdList></Reference><Reference><Citation>Umapathi &#xa0;T, Poh &#xa0;MQW, Fan &#xa0;BE, Li &#xa0;KFC, George &#xa0;J, Tan &#xa0;JYL. Acute hyperhidrosis and postural tachycardia in a COVID-19 patient. Clin Auton Res &#xa0;2020;30:571&#x2013;573.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7511524</ArticleId><ArticleId IdType="pubmed">32970212</ArticleId></ArticleIdList></Reference><Reference><Citation>Blitshteyn &#xa0;S, Whitelaw &#xa0;S. Postural orthostatic tachycardia syndrome (POTS) and other autonomic disorders after COVID-19 infection: a case series of 20 patients. Immunol Res &#xa0;2021;69:205&#x2013;211.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8009458</ArticleId><ArticleId IdType="pubmed">33786700</ArticleId></ArticleIdList></Reference><Reference><Citation>Chioh &#xa0;FW, Fong &#xa0;SW, Young &#xa0;BE, Wu &#xa0;KX, Siau &#xa0;A, Krishnan &#xa0;S, et al. &#xa0;Convalescent COVID-19 patients are susceptible to endothelial dysfunction due to persistent immune activation. Elife &#xa0;2021;10:e64909.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7987341</ArticleId><ArticleId IdType="pubmed">33752798</ArticleId></ArticleIdList></Reference><Reference><Citation>Gavriilaki &#xa0;E, Eftychidis &#xa0;I, Papassotiriou &#xa0;I. Update on endothelial dysfunction in COVID-19: severe disease, long COVID-19 and pediatric characteristics. J Lab Med &#xa0;2021;45:293&#x2013;302.</Citation></Reference><Reference><Citation>Ho &#xa0;FK, Man &#xa0;KK, Toshner &#xa0;M, Church &#xa0;C, Celis-Morales &#xa0;C, Wong &#xa0;IC, et al. &#xa0;Thromboembolic risk in hospitalised and non-hospitalised COVID-19 patients: a self-controlled case series analysis of a nation-wide cohort. Mayo Clin Proc &#xa0;2021;96:2587&#x2013;2597.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8282478</ArticleId><ArticleId IdType="pubmed">34607634</ArticleId></ArticleIdList></Reference><Reference><Citation>Libby &#xa0;P, L&#xfc;scher &#xa0;T. COVID-19 is, in the end, an endothelial disease. Eur Heart J &#xa0;2020;41:3038&#x2013;3044.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7470753</ArticleId><ArticleId IdType="pubmed">32882706</ArticleId></ArticleIdList></Reference><Reference><Citation>Lukose &#xa0;T, De &#xa0;S, Ganga &#xa0;R, Ravina &#xa0;M, Sahu &#xa0;D, Moideen &#xa0;A, et al. &#xa0;Lung perfusion SPECT/CT imaging in post COVID-19 pneumonia: the spectrum of imaging findings. J Nucl Med &#xa0;2021;62:2002.</Citation></Reference><Reference><Citation>Patelli &#xa0;G, Paganoni &#xa0;S, Besana &#xa0;F, Codazzi &#xa0;F, Ronzoni &#xa0;M, Manini &#xa0;S, et al. &#xa0;Preliminary detection of lung hypoperfusion in discharged Covid-19 patients during recovery. Eur J Radiol &#xa0;2020;129:109121.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7280822</ArticleId><ArticleId IdType="pubmed">32540586</ArticleId></ArticleIdList></Reference><Reference><Citation>Thornton &#xa0;G, Shetye &#xa0;A, Knott &#xa0;K, Razvi &#xa0;Y, Vimalesvaran &#xa0;K, Kurdi &#xa0;H, et al. &#xa0;Myocardial perfusion after COVID-19 infection: no persisting impaired myocardial blood flow in surviving patients. Eur Heart J Cardiovasc Imaging &#xa0;2021;22:jeab090.</Citation></Reference><Reference><Citation>Mangion &#xa0;K, Morrow &#xa0;A, Bagot &#xa0;C, Bayes &#xa0;H, Blyth &#xa0;KG, Church &#xa0;C, et al. &#xa0;The chief scientist office cardiovascular and pulmonary imaging in SARS coronavirus disease-19 (CISCO-19) study. Cardiovasc Res &#xa0;2020;116:2185&#x2013;2196.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7454350</ArticleId><ArticleId IdType="pubmed">32702087</ArticleId></ArticleIdList></Reference><Reference><Citation>Tholin &#xa0;B, Ghanima &#xa0;W, Einvik &#xa0;G, Aarli &#xa0;B, Br&#xf8;nstad &#xa0;E, Skj&#xf8;nsberg &#xa0;OH, et al. &#xa0;Incidence of thrombotic complications in hospitalised and non-hospitalised patients after COVID-19 diagnosis. Br J Haematol &#xa0;2021;194:542&#x2013;546.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8239792</ArticleId><ArticleId IdType="pubmed">34028814</ArticleId></ArticleIdList></Reference><Reference><Citation>Drake &#xa0;TM, Riad &#xa0;AM, Fairfield &#xa0;CJ, Egan &#xa0;C, Knight &#xa0;SR, Pius &#xa0;R, et al. &#xa0;Characterisation of in-hospital complications associated with COVID-19 using the ISARIC WHO Clinical Characterisation Protocol UK: a prospective, multicentre cohort study. Lancet &#xa0;2021;398:223&#x2013;237.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8285118</ArticleId><ArticleId IdType="pubmed">34274064</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang &#xa0;C, Wang &#xa0;Y, Li &#xa0;X, Ren &#xa0;L, Zhao &#xa0;J, Hu &#xa0;Y, et al. &#xa0;Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet &#xa0;2020;395:497&#x2013;506.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7159299</ArticleId><ArticleId IdType="pubmed">31986264</ArticleId></ArticleIdList></Reference><Reference><Citation>Inciardi &#xa0;RM, Adamo &#xa0;M, Lupi &#xa0;L, Cani &#xa0;DS, Di Pasquale &#xa0;M, Tomasoni &#xa0;D, et al. &#xa0;Characteristics and outcomes of patients hospitalized for COVID-19 and cardiac disease in Northern Italy. Eur Heart J &#xa0;2020;41:1821&#x2013;1829.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7239204</ArticleId><ArticleId IdType="pubmed">32383763</ArticleId></ArticleIdList></Reference><Reference><Citation>Alvarez-Garcia &#xa0;J, Lee &#xa0;S, Gupta &#xa0;A, Cagliostro &#xa0;M, Joshi &#xa0;AA, Rivas-Lasarte &#xa0;M, et al. &#xa0;Prognostic impact of prior heart failure in patients hospitalized with COVID-19. J Am Coll Cardiol &#xa0;2020;76:2334&#x2013;2348.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7598769</ArticleId><ArticleId IdType="pubmed">33129663</ArticleId></ArticleIdList></Reference><Reference><Citation>Chatrath &#xa0;N, Kaza &#xa0;N, Pabari &#xa0;PA, Fox &#xa0;K, Mayet &#xa0;J, Barton &#xa0;C, et al. &#xa0;The effect of concomitant COVID-19 infection on outcomes in patients hospitalized with heart failure. ESC Heart Fail &#xa0;2020;7:4443&#x2013;4447.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7675415</ArticleId><ArticleId IdType="pubmed">33040480</ArticleId></ArticleIdList></Reference><Reference><Citation>Rey &#xa0;JR, Caro-Cod&#xf3;n &#xa0;J, Rosillo &#xa0;SO, Iniesta &#xa0;&#xc1;M, Castrej&#xf3;n-Castrej&#xf3;n &#xa0;S, Marco-Clement &#xa0;I, et al. &#xa0;Heart failure in COVID-19 patients: prevalence, incidence and prognostic implications. Eur J Heart Fail &#xa0;2020;22:2205&#x2013;2215.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7461427</ArticleId><ArticleId IdType="pubmed">32833283</ArticleId></ArticleIdList></Reference><Reference><Citation>Halliday &#xa0;BP, Wassall &#xa0;R, Lota &#xa0;AS, Khalique &#xa0;Z, Gregson &#xa0;J, Newsome &#xa0;S, et al. &#xa0;Withdrawal of pharmacological treatment for heart failure in patients with recovered dilated cardiomyopathy (TRED-HF): an open-label, pilot, randomised trial. Lancet &#xa0;2019;393:61&#x2013;73.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6319251</ArticleId><ArticleId IdType="pubmed">30429050</ArticleId></ArticleIdList></Reference><Reference><Citation>Arrigo &#xa0;M, Nijst &#xa0;P, Rudiger &#xa0;A. Optimising heart failure therapies in the acute setting. Card Fail Rev &#xa0;2018;4:38&#x2013;42.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5971667</ArticleId><ArticleId IdType="pubmed">29892475</ArticleId></ArticleIdList></Reference><Reference><Citation>Sandoval &#xa0;Y, Januzzi Jr &#xa0;JL, Jaffe &#xa0;AS. Cardiac troponin for the diagnosis and risk-stratification of myocardial injury in COVID-19: JACC review topic of the week. J Am Coll Cardiol &#xa0;2020;76:1244&#x2013;1258.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7833921</ArticleId><ArticleId IdType="pubmed">32652195</ArticleId></ArticleIdList></Reference><Reference><Citation>Varga &#xa0;Z, Flammer &#xa0;AJ, Steiger &#xa0;P, Haberecker &#xa0;M, Andermatt &#xa0;R, Zinkernagel &#xa0;AS, et al. &#xa0;Endothelial cell infection and endotheliitis in COVID-19. Lancet &#xa0;2020;395:1417&#x2013;1418.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7172722</ArticleId><ArticleId IdType="pubmed">32325026</ArticleId></ArticleIdList></Reference><Reference><Citation>Evans &#xa0;PC, Rainger &#xa0;GE, Mason &#xa0;JC, Guzik &#xa0;TJ, Osto &#xa0;E, Stamataki &#xa0;Z, et al. &#xa0;Endothelial dysfunction in COVID-19: a position paper of the ESC working group for atherosclerosis and vascular biology, and the ESC council of basic cardiovascular science. Cardiovasc Res &#xa0;2020;116:2177&#x2013;2184.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7454368</ArticleId><ArticleId IdType="pubmed">32750108</ArticleId></ArticleIdList></Reference><Reference><Citation>Robbins-Juarez &#xa0;SY, Qian &#xa0;L, King &#xa0;KL, Stevens &#xa0;JS, Husain &#xa0;SA, Radhakrishnan &#xa0;J, et al. &#xa0;Outcomes for patients with COVID-19 and acute kidney injury: a systematic review and meta-analysis. Kidney Int Rep &#xa0;2020;5:1149&#x2013;1160.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7314696</ArticleId><ArticleId IdType="pubmed">32775814</ArticleId></ArticleIdList></Reference><Reference><Citation>New &#xa0;MI, Peterson &#xa0;RE, Saenger &#xa0;P, Levine &#xa0;LS. Evidence for an unidentified ACTH-induced steroid hormone causing hypertension. J Clin Endocrinol Metab &#xa0;1976;43:1283&#x2013;1293.</Citation><ArticleIdList><ArticleId IdType="pubmed">187612</ArticleId></ArticleIdList></Reference><Reference><Citation>Dustan &#xa0;HP, Bravo &#xa0;EL, Tarazi &#xa0;RC. Volume-dependent essential and steroid hypertension. Am J Cardiol &#xa0;1973;31:606&#x2013;615.</Citation><ArticleIdList><ArticleId IdType="pubmed">4698131</ArticleId></ArticleIdList></Reference><Reference><Citation>Phelan &#xa0;D, Kim &#xa0;JH, Elliott &#xa0;MD, Wasfy &#xa0;MM, Cremer &#xa0;P, Johri &#xa0;AM, et al. &#xa0;Screening of potential cardiac involvement in competitive athletes recovering from COVID-19. JACC Cardiovasc Imaging &#xa0;2020;13:2635&#x2013;2652.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7598679</ArticleId><ArticleId IdType="pubmed">33303102</ArticleId></ArticleIdList></Reference><Reference><Citation>Dixit &#xa0;NM, Churchill &#xa0;A, Nsair &#xa0;A, Hsu &#xa0;JJ. Post-acute COVID-19 syndrome and the cardiovascular system: what is known? &#xa0;Am Heart J Plus &#xa0;2021;5:100025.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8223036</ArticleId><ArticleId IdType="pubmed">34192289</ArticleId></ArticleIdList></Reference><Reference><Citation>Mitrani &#xa0;RD, Dabas &#xa0;N, Goldberger &#xa0;JJ. COVID-19 cardiac injury: implications for long-term surveillance and outcomes in survivors. Heart Rhythm &#xa0;2020;17:1984&#x2013;1990.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7319645</ArticleId><ArticleId IdType="pubmed">32599178</ArticleId></ArticleIdList></Reference><Reference><Citation>Daynes &#xa0;E, Gerlis &#xa0;C, Chaplin &#xa0;E, Gardiner &#xa0;N, Singh &#xa0;SJ. Early experiences of rehabilitation for individuals post-COVID to improve fatigue, breathlessness exercise capacity and cognition&#x2014;a cohort study. Chron Respir Dis &#xa0;2021;18:147997312110156.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8114752</ArticleId><ArticleId IdType="pubmed">33957805</ArticleId></ArticleIdList></Reference><Reference><Citation>Thomas &#xa0;P, Baldwin &#xa0;C, Bissett &#xa0;B, Boden &#xa0;I, Gosselink &#xa0;R, Granger &#xa0;CL, et al. &#xa0;Physiotherapy management for COVID-19 in the acute hospital setting: clinical practice recommendations. J Physiother &#xa0;2020;66:73&#x2013;82.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7165238</ArticleId><ArticleId IdType="pubmed">32312646</ArticleId></ArticleIdList></Reference><Reference><Citation>Naidu &#xa0;SB, Shah &#xa0;AJ, Saigal &#xa0;A, Smith &#xa0;C, Brill &#xa0;SE, Goldring &#xa0;J, et al. &#xa0;The high mental health burden of &#x201c;Long COVID&#x201d; and its association with on-going physical and respiratory symptoms in all adults discharged from hospital. Eur Respir J &#xa0;2021;57:2004364.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8015645</ArticleId><ArticleId IdType="pubmed">33795319</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhatia &#xa0;RT, Marwaha &#xa0;S, Malhotra &#xa0;A, Iqbal &#xa0;Z, Hughes &#xa0;C, B&#xf6;rjesson &#xa0;M, et al. &#xa0;Exercise in the Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) era: a question and answer session with the experts endorsed by the section of sports cardiology &amp; exercise of the European Association of Preventive Cardiology (EAPC). Eur J Prev Cardiol &#xa0;2020;27:1242&#x2013;1251.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7717284</ArticleId><ArticleId IdType="pubmed">32475157</ArticleId></ArticleIdList></Reference><Reference><Citation>Santos-Ferreira &#xa0;D, Tom&#xe1;s &#xa0;R, Dores &#xa0;H. Return-to-play guidelines for athletes after COVID-19 infection. JAMA Cardiol &#xa0;2021;6:478&#x2013;479.</Citation><ArticleIdList><ArticleId IdType="pubmed">33146665</ArticleId></ArticleIdList></Reference><Reference><Citation>Elliott &#xa0;N, Martin &#xa0;R, Heron &#xa0;N, Elliott &#xa0;J, Grimstead &#xa0;D, Biswas &#xa0;A. Infographic. Graduated return to play guidance following COVID-19 infection. Br J Sports Med &#xa0;2020;54:1174&#x2013;1175.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7371566</ArticleId><ArticleId IdType="pubmed">32571796</ArticleId></ArticleIdList></Reference><Reference><Citation>Pelliccia &#xa0;A, Solberg &#xa0;EE, Papadakis &#xa0;M, Adami &#xa0;PE, Biffi &#xa0;A, Caselli &#xa0;S, et al. &#xa0;Recommendations for participation in competitive and leisure time sport in athletes with cardiomyopathies, myocarditis, and pericarditis: position statement of the Sport Cardiology Section of the European Association of Preventive Cardiology (EAPC). Eur Heart J &#xa0;2019;40:19&#x2013;33.</Citation><ArticleIdList><ArticleId IdType="pubmed">30561613</ArticleId></ArticleIdList></Reference><Reference><Citation>
University College London. Long Covid: UCL leads &#xa3;8m studies into treatments and diagnosis. https://www.ucl.ac.uk/news/headlines/2021/jul/ucl-leads-ps8m-studies-long-covid-treatments-and-diagnosis (19 July 2021).</Citation></Reference><Reference><Citation>Collet &#xa0;JP, Thiele &#xa0;H, Barbato &#xa0;E, Barth&#xe9;l&#xe9;my &#xa0;O, Bauersachs &#xa0;J, Bhatt &#xa0;DL, et al. &#xa0;2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: the task force for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J &#xa0;2021;42:1289&#x2013;1367.</Citation><ArticleIdList><ArticleId IdType="pubmed">32860058</ArticleId></ArticleIdList></Reference><Reference><Citation>Ezra A &#xa0;A, Nanette K &#xa0;W, Ralph G &#xa0;B, Donald E &#xa0;C, Theodore G &#xa0;G, David R &#xa0;H, et al. &#xa0;2014 AHA/ACC guideline for the management of patients with non-ST-elevation acute coronary syndromes. J Am Coll Cardiol &#xa0;2014;64:e139&#x2013;e228.</Citation><ArticleIdList><ArticleId IdType="pubmed">25260718</ArticleId></ArticleIdList></Reference><Reference><Citation>Crespo-Leiro &#xa0;MG, Metra &#xa0;M, Lund &#xa0;LH, Milicic &#xa0;D, Costanzo &#xa0;MR, Filippatos &#xa0;G, et al. &#xa0;Advanced heart failure: a position statement of the heart failure association of the European Society of Cardiology. Eur J Heart Fail &#xa0;2018;20:1505&#x2013;1535.</Citation><ArticleIdList><ArticleId IdType="pubmed">29806100</ArticleId></ArticleIdList></Reference><Reference><Citation>Yancy &#xa0;CW, Jessup &#xa0;M, Bozkurt &#xa0;B, Butler &#xa0;J, Casey &#xa0;DE, Colvin &#xa0;MM, et al. &#xa0;2017 ACC/AHA/HFSA focused update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America. Circulation &#xa0;2017;136:e137&#x2013;e161.</Citation><ArticleIdList><ArticleId IdType="pubmed">28455343</ArticleId></ArticleIdList></Reference><Reference><Citation>
ClinicalTrials.gov. HElping Alleviate the Longer-term Consequences of COVID-19 (HEAL-COVID) (HEAL-COVID) &#xa0;2021. https://clinicaltrials.gov/ct2/show/NCT04801940 (8 August 2021).</Citation></Reference><Reference><Citation>Greenhalgh &#xa0;T, Knight &#xa0;M, A&#x2019;Court &#xa0;C, Buxton &#xa0;M, Husain &#xa0;L. Management of post-acute Covid-19 in primary care. BMJ &#xa0;2020;370:m3026.</Citation><ArticleIdList><ArticleId IdType="pubmed">32784198</ArticleId></ArticleIdList></Reference><Reference><Citation>Richette &#xa0;P, Poitou &#xa0;C, Garnero &#xa0;P, Vicaut &#xa0;E, Bouillot &#xa0;JL, Lacorte &#xa0;JM, et al. &#xa0;Benefits of massive weight loss on symptoms, systemic inflammation and cartilage turnover in obese patients with knee osteoarthritis. Ann Rheum Dis &#xa0;2011;70:139&#x2013;144.</Citation><ArticleIdList><ArticleId IdType="pubmed">20980288</ArticleId></ArticleIdList></Reference><Reference><Citation>Monteiro &#xa0;R, Azevedo &#xa0;I. Chronic inflammation in obesity and the metabolic syndrome. Mediators Inflamm &#xa0;2010;2010:1&#x2013;10.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2913796</ArticleId><ArticleId IdType="pubmed">20706689</ArticleId></ArticleIdList></Reference><Reference><Citation>Koenen &#xa0;M, Hill &#xa0;MA, Cohen &#xa0;P, Obesity &#xa0;SJ. Adipose tissue and vascular dysfunction. Circ Res &#xa0;2021;128:951&#x2013;968.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8026272</ArticleId><ArticleId IdType="pubmed">33793327</ArticleId></ArticleIdList></Reference><Reference><Citation>Knowler &#xa0;WC, Barrett-Connor &#xa0;E, Fowler &#xa0;SE, Hamman &#xa0;RF, Lachin &#xa0;JM, Walker &#xa0;EA, et al. &#xa0;Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med &#xa0;2002;346:393&#x2013;403.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1370926</ArticleId><ArticleId IdType="pubmed">11832527</ArticleId></ArticleIdList></Reference><Reference><Citation>Gloeckl &#xa0;R, Leitl &#xa0;D, Jarosch &#xa0;I, Schneeberger &#xa0;T, Nell &#xa0;C, Stenzel &#xa0;N, et al. &#xa0;Benefits of pulmonary rehabilitation in COVID-19: a prospective observational cohort study. ERJ Open Res &#xa0;2021;7:00108&#x2013;2021.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7957293</ArticleId><ArticleId IdType="pubmed">34095290</ArticleId></ArticleIdList></Reference><Reference><Citation>Asly &#xa0;M, Hazim &#xa0;A. Rehabilitation of post-COVID-19 patients. Pan Afr Med J &#xa0;2020;36:168.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7467884</ArticleId><ArticleId IdType="pubmed">32952812</ArticleId></ArticleIdList></Reference><Reference><Citation>Jones &#xa0;M, Harvey &#xa0;A, Marston &#xa0;L, O&#x2019;Connell &#xa0;NE. Breathing exercises for dysfunctional breathing/hyperventilation syndrome in adults. Cochrane Database Syst Rev &#xa0;2013;5:CD009041.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11379427</ArticleId><ArticleId IdType="pubmed">23728685</ArticleId></ArticleIdList></Reference><Reference><Citation>Crook &#xa0;H, Raza &#xa0;S, Nowell &#xa0;J, Young &#xa0;M, Edison &#xa0;P. Long covid&#x2014;mechanisms, risk factors, and management. BMJ &#xa0;2021;374:n1648.</Citation><ArticleIdList><ArticleId IdType="pubmed">34312178</ArticleId></ArticleIdList></Reference><Reference><Citation>Lord &#xa0;VM, Cave &#xa0;P, Hume &#xa0;VJ, Flude &#xa0;EJ, Evans &#xa0;A, Kelly &#xa0;JL, et al. &#xa0;Singing teaching as a therapy for chronic respiratory disease&#x2014;a randomised controlled trial and qualitative evaluation. BMC Pulm Med &#xa0;2010;10:41.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2920262</ArticleId><ArticleId IdType="pubmed">20682030</ArticleId></ArticleIdList></Reference><Reference><Citation>Habersaat &#xa0;KB, Betsch &#xa0;C, Danchin &#xa0;M, Sunstein &#xa0;CR, B&#xf6;hm &#xa0;R, Falk &#xa0;A, et al. &#xa0;Ten considerations for effectively managing the COVID-19 transition. Nat Hum Behav &#xa0;2020;4:677&#x2013;687.</Citation><ArticleIdList><ArticleId IdType="pubmed">32581299</ArticleId></ArticleIdList></Reference><Reference><Citation>

Park &#xa0;CC, Chaturvedi &#xa0;N, Sterne &#xa0;J, Steves &#xa0;C, Williams &#xa0;D. Short report on long COVID. https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/1007511/S1327_Short_Long_COVID_report.pdf (22 July 2021).</Citation></Reference><Reference><Citation>Arnold &#xa0;AC, Okamoto &#xa0;LE, Diedrich &#xa0;A, Paranjape &#xa0;SY, Raj &#xa0;SR, Biaggioni &#xa0;I, et al. &#xa0;Low-dose propranolol and exercise capacity in postural tachycardia syndrome. A randomized study. Neurology &#xa0;2013;80:1927&#x2013;1933.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3716342</ArticleId><ArticleId IdType="pubmed">23616163</ArticleId></ArticleIdList></Reference><Reference><Citation>Parsaik &#xa0;A, Allison &#xa0;TG, Singer &#xa0;W, Sletten &#xa0;DM, Joyner &#xa0;MJ, Benarroch &#xa0;EE, et al. &#xa0;Deconditioning in patients with orthostatic intolerance. Neurology &#xa0;2012;79:1435.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3525293</ArticleId><ArticleId IdType="pubmed">22993288</ArticleId></ArticleIdList></Reference><Reference><Citation>Podoleanu &#xa0;C, Maggi &#xa0;R, Brignole &#xa0;M, Croci &#xa0;F, Incze &#xa0;A, Solano &#xa0;A, et al. &#xa0;Lower limb and abdominal compression bandages prevent progressive orthostatic hypotension in elderly persons: a randomized single-blind controlled study. J Am Coll Cardiol &#xa0;2006;48:1425&#x2013;1432.</Citation><ArticleIdList><ArticleId IdType="pubmed">17010806</ArticleId></ArticleIdList></Reference><Reference><Citation>Freeman &#xa0;R, Abuzinadah &#xa0;AR, Gibbons &#xa0;C, Jones &#xa0;P, Miglis &#xa0;MG, Sinn &#xa0;DI. Orthostatic hypotension. J Am Coll Cardiol &#xa0;2018;72:1294&#x2013;1309.</Citation><ArticleIdList><ArticleId IdType="pubmed">30190008</ArticleId></ArticleIdList></Reference><Reference><Citation>Collaborative Group RECOVERY, Horby &#xa0;P, Lim &#xa0;WS, Emberson &#xa0;JR, Mafham &#xa0;M, Bell &#xa0;JL, et al. &#xa0;Dexamethasone in hospitalized patients with Covid-19. N Engl J Med &#xa0;2021;384:693&#x2013;704.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7383595</ArticleId><ArticleId IdType="pubmed">32678530</ArticleId></ArticleIdList></Reference><Reference><Citation>Stone &#xa0;JH, Frigault &#xa0;MJ, Serling-Boyd &#xa0;NJ, Fernandes &#xa0;AD, Harvey &#xa0;L, Foulkes &#xa0;AS, et al. &#xa0;Efficacy of tocilizumab in patients hospitalized with Covid-19. N Engl J Med &#xa0;2020;383:2333&#x2013;2344.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7646626</ArticleId><ArticleId IdType="pubmed">33085857</ArticleId></ArticleIdList></Reference><Reference><Citation>Beigel &#xa0;JH, Tomashek &#xa0;KM, Dodd &#xa0;LE, Mehta &#xa0;AK, Zingman &#xa0;BS, Kalil &#xa0;AC, et al. &#xa0;Remdesivir for the treatment of Covid-19&#x2014;final report. N Engl J Med &#xa0;2020;383:1813&#x2013;1826.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7262788</ArticleId><ArticleId IdType="pubmed">32445440</ArticleId></ArticleIdList></Reference><Reference><Citation>RECOVERY Collaborative Group. Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. Lancet &#xa0;2022;399:143&#x2013;151.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8598213</ArticleId><ArticleId IdType="pubmed">34800427</ArticleId></ArticleIdList></Reference><Reference><Citation>Connors &#xa0;JM, Brooks &#xa0;MM, Sciurba &#xa0;FC, Krishnan &#xa0;JA, Bledsoe &#xa0;JR, Kindzelski &#xa0;A, et al. &#xa0;Effect of antithrombotic therapy on clinical outcomes in outpatients with clinically stable symptomatic COVID-19: the ACTIV-4B randomized clinical trial. JAMA &#xa0;2021;326:1703&#x2013;1712.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8506296</ArticleId><ArticleId IdType="pubmed">34633405</ArticleId></ArticleIdList></Reference><Reference><Citation>REMAP-CAP Investigators; ACTIV-4a Investigators; ATTACC Investigators; Goligher &#xa0;EC, Bradbury &#xa0;CA, McVerry &#xa0;BJ, et al. &#xa0;Therapeutic anticoagulation with heparin in critically ill patients with Covid-19. N Engl J Med &#xa0;2021;385:777&#x2013;789.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8362592</ArticleId><ArticleId IdType="pubmed">34351722</ArticleId></ArticleIdList></Reference><Reference><Citation>Lawler &#xa0;PR, Goligher &#xa0;EC, Berger &#xa0;JS, Neal &#xa0;MD, McVerry &#xa0;BJ, Nicolau &#xa0;JC, et al. &#xa0;Therapeutic anticoagulation with heparin in noncritically Ill patients with Covid-19. N Engl J Med &#xa0;2021;385:790&#x2013;802.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8362594</ArticleId><ArticleId IdType="pubmed">34351721</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopes &#xa0;RD, Furtado &#xa0;RH, Macedo &#xa0;AVS, Bronhara &#xa0;B, Damiani &#xa0;LP, Barbosa &#xa0;LM, et al. &#xa0;Therapeutic versus prophylactic anticoagulation for patients admitted to hospital with COVID-19 and elevated D-dimer concentration (ACTION): an open-label, multicentre, randomised, controlled trial. Lancet &#xa0;2021;397:2253&#x2013;2263.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8177770</ArticleId><ArticleId IdType="pubmed">34097856</ArticleId></ArticleIdList></Reference><Reference><Citation>Sadeghipour &#xa0;P, Talasaz &#xa0;A, Rashidi &#xa0;F, Sharif-Kashani &#xa0;B, Beigmohammadi &#xa0;M, Farrokhpour &#xa0;M, et al. &#xa0;Effect of inter-mediate-dose vs standard-dose prophylactic anticoagulation on thrombotic events, extracorporeal membrane oxygenation treatment, or mortality among patients with COVID-19 admitted to the intensive care unit: the INSPIRATION randomized clinical trial. JAMA &#xa0;2021;325:1620&#x2013;1630.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7974835</ArticleId><ArticleId IdType="pubmed">33734299</ArticleId></ArticleIdList></Reference><Reference><Citation>Sholzberg &#xa0;M, Tang &#xa0;GH, Rahhal &#xa0;H, AlHamzah &#xa0;M, Kreuziger &#xa0;LB, N&#xed; &#xc1;inle &#xa0;F, et al. &#xa0;Heparin for moderately Ill patients with Covid-19. medRxiv &#xa0;2021. doi:10.1101/2021.07.08.21259351.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2021.07.08.21259351</ArticleId><ArticleId IdType="pubmed">0</ArticleId></ArticleIdList></Reference><Reference><Citation>McDonald &#xa0;I, Murray &#xa0;SM, Reynolds &#xa0;CJ, Altmann &#xa0;DM, Boyton &#xa0;RJ. Comparative systematic review and meta-analysis of reactogenicity, immunogenicity and efficacy of vaccines against SARS-CoV-2. NPJ Vaccines &#xa0;2021;6:74.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8116645</ArticleId><ArticleId IdType="pubmed">33986272</ArticleId></ArticleIdList></Reference><Reference><Citation>Polack &#xa0;FP, Thomas &#xa0;SJ, Kitchin &#xa0;N, Absalon &#xa0;J, Gurtman &#xa0;A, Lockhart &#xa0;S, et al. &#xa0;Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine. N Engl J Med &#xa0;2020;383:2603&#x2013;2615.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7745181</ArticleId><ArticleId IdType="pubmed">33301246</ArticleId></ArticleIdList></Reference><Reference><Citation>Haas &#xa0;EJ, Angulo &#xa0;FJ, McLaughlin &#xa0;JM, Anis &#xa0;E, Singer &#xa0;SR, Khan &#xa0;F, et al. &#xa0;Impact and effectiveness of mRNA BNT162b2 vaccine against SARS-CoV-2 infections and COVID-19 cases, hospitalisations, and deaths following a nationwide vaccination campaign in Israel: an observational study using national surveillance data. Lancet &#xa0;2021;397:1819&#x2013;1829.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8099315</ArticleId><ArticleId IdType="pubmed">33964222</ArticleId></ArticleIdList></Reference><Reference><Citation>Sadoff &#xa0;J, Gray &#xa0;G, Vandebosch &#xa0;A, C&#xe1;rdenas &#xa0;V, Shukarev &#xa0;G, Grinsztejn &#xa0;B, et al. &#xa0;Safety and efficacy of single-dose Ad26.COV2.S vaccine against Covid-19. N Engl J Med &#xa0;2021;384:2187&#x2013;2201.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8220996</ArticleId><ArticleId IdType="pubmed">33882225</ArticleId></ArticleIdList></Reference><Reference><Citation>Logunov &#xa0;DY, Dolzhikova &#xa0;IV, Shcheblyakov &#xa0;DV, Tukhvatulin &#xa0;AI, Zubkova &#xa0;OV, Dzharullaeva &#xa0;AS, et al. &#xa0;Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia. Lancet &#xa0;2021;397:671&#x2013;681.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7852454</ArticleId><ArticleId IdType="pubmed">33545094</ArticleId></ArticleIdList></Reference><Reference><Citation>Tanriover &#xa0;MD, Do&#x11f;anay &#xa0;HL, Akova &#xa0;M, G&#xfc;ner &#xa0;HR, Azap &#xa0;A, Akhan &#xa0;S, et al. &#xa0;Efficacy and safety of an inactivated whole-virion SARS-CoV-2 vaccine (CoronaVac): interim results of a double-blind, randomised, placebo-controlled, phase 3 trial in Turkey. Lancet &#xa0;2021;398:213&#x2013;222.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8266301</ArticleId><ArticleId IdType="pubmed">34246358</ArticleId></ArticleIdList></Reference><Reference><Citation>Shinde &#xa0;V, Bhikha &#xa0;S, Hoosain &#xa0;Z, Archary &#xa0;M, Bhorat &#xa0;Q, Fairlie &#xa0;L, et al. &#xa0;Efficacy of NVX-CoV2373 Covid-19 vaccine against the B.1.351 variant. N Engl J Med &#xa0;2021;384:1899&#x2013;1909.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8091623</ArticleId><ArticleId IdType="pubmed">33951374</ArticleId></ArticleIdList></Reference><Reference><Citation>Udell &#xa0;JA, Zawi &#xa0;R, Bhatt &#xa0;DL, Keshtkar-Jahromi &#xa0;M, Gaughran &#xa0;F, Phrommintikul &#xa0;A, et al. &#xa0;Association between influenza vaccination and cardiovascular outcomes in high-risk patients: a meta-analysis. JAMA &#xa0;2013;310:1711&#x2013;1720.</Citation><ArticleIdList><ArticleId IdType="pubmed">24150467</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnstone &#xa0;J, Loeb &#xa0;M, Teo &#xa0;KK, Gao &#xa0;P, Dyal &#xa0;L, Liu &#xa0;L, et al. &#xa0;Influenza vaccination and major adverse vascular events in high-risk patients. Circulation &#xa0;2012;126:278&#x2013;286.</Citation><ArticleIdList><ArticleId IdType="pubmed">22715472</ArticleId></ArticleIdList></Reference><Reference><Citation>Strain &#xa0;WD, Sherwood &#xa0;O, Banerjee &#xa0;A, Vvd &#xa0;T, Hishmeh &#xa0;L, Rossman &#xa0;J. The impact of COVID vaccination on symptoms of long COVID. An international survey of people with lived experience of long COVID. SSRN &#xa0;2021. doi:10.2139/ssrn.3868856.</Citation><ArticleIdList><ArticleId IdType="doi">10.2139/ssrn.3868856</ArticleId><ArticleId IdType="pmc">PMC9146071</ArticleId><ArticleId IdType="pubmed">35632408</ArticleId></ArticleIdList></Reference><Reference><Citation>Antonelli &#xa0;M, Penfold &#xa0;RS, Merino &#xa0;J, Sudre &#xa0;CH, Molteni &#xa0;E, Berry &#xa0;S, et al. &#xa0;Post-vaccination SARS-CoV-2 infection: risk factors and illness profile in a prospective, observational community-based case&#x2013;control study. medRxiv &#xa0;2021. doi:10.1101/2021.05.24.21257738.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2021.05.24.21257738</ArticleId><ArticleId IdType="pubmed">0</ArticleId></ArticleIdList></Reference><Reference><Citation>Antonelli &#xa0;M, Penfold &#xa0;RS, Merino &#xa0;J, Sudre &#xa0;CH, Molteni &#xa0;E, Berry &#xa0;S, et al. &#xa0;Risk factors and disease profile of post-vaccination SARS-CoV-2 infection in UK users of the COVID Symptom Study app: a prospective, community-based, nested, case&#x2013;control study. Lancet Infect Dis &#xa0;2022;22:43&#x2013;55.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8409907</ArticleId><ArticleId IdType="pubmed">34480857</ArticleId></ArticleIdList></Reference><Reference><Citation>Levine-Tiefenbrun &#xa0;M, Yelin &#xa0;I, Katz &#xa0;R, Herzel &#xa0;E, Golan &#xa0;Z, Schreiber &#xa0;L, et al. &#xa0;Initial report of decreased SARS-CoV-2 viral load after inoculation with the BNT162b2 vaccine. Nat Med &#xa0;2021;27:790&#x2013;792.</Citation><ArticleIdList><ArticleId IdType="pubmed">33782619</ArticleId></ArticleIdList></Reference><Reference><Citation>Murphy &#xa0;J, Valli&#xe8;res &#xa0;F, Bentall &#xa0;RP, Shevlin &#xa0;M, McBride &#xa0;O, Hartman &#xa0;TK, et al. &#xa0;Psychological characteristics associated with COVID-19 vaccine hesitancy and resistance in Ireland and the United Kingdom. Nat Commun &#xa0;2021;12:1&#x2013;15.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7782692</ArticleId><ArticleId IdType="pubmed">33397962</ArticleId></ArticleIdList></Reference><Reference><Citation>Baden &#xa0;LR, El Sahly &#xa0;HM, Essink &#xa0;B, Kotloff &#xa0;K, Frey &#xa0;S, Novak &#xa0;R, et al. &#xa0;Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine. N Engl J Med &#xa0;2021;384:403&#x2013;416.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7787219</ArticleId><ArticleId IdType="pubmed">33378609</ArticleId></ArticleIdList></Reference><Reference><Citation>Folegatti &#xa0;PM, Ewer &#xa0;KJ, Aley &#xa0;PK, Angus &#xa0;B, Becker &#xa0;S, Belij-Rammerstorfer &#xa0;S, et al. &#xa0;Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial. Lancet &#xa0;2020;396:467&#x2013;478.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7445431</ArticleId><ArticleId IdType="pubmed">32702298</ArticleId></ArticleIdList></Reference><Reference><Citation>Larson &#xa0;KF, Ammirati &#xa0;E, Adler &#xa0;ED, Cooper &#xa0;LT, Hong &#xa0;KN, Saponara &#xa0;G, et al. &#xa0;Myocarditis after BNT162b2 and mRNA-1273 vaccination. Circulation &#xa0;2021;144:506&#x2013;508.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8340725</ArticleId><ArticleId IdType="pubmed">34133884</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim &#xa0;HW, Jenista &#xa0;ER, Wendell &#xa0;DC, Azevedo &#xa0;CF, Campbell &#xa0;MJ, Darty &#xa0;SN, et al. &#xa0;Patients with acute myocarditis following mRNA COVID-19 vaccination. JAMA Cardiol &#xa0;2021.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8243258</ArticleId><ArticleId IdType="pubmed">34185046</ArticleId></ArticleIdList></Reference><Reference><Citation>Bozkurt &#xa0;B, Kamat &#xa0;I, Hotez &#xa0;PJ. Myocarditis with COVID-19 mRNA vaccines. Circulation &#xa0;2021;144:471&#x2013;484.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8340726</ArticleId><ArticleId IdType="pubmed">34281357</ArticleId></ArticleIdList></Reference><Reference><Citation>Greinacher &#xa0;A, Thiele &#xa0;T, Warkentin &#xa0;TE, Weisser &#xa0;K, Kyrle &#xa0;PA, Eichinger &#xa0;S. Thrombotic thrombocytopenia after ChAdOx1 nCov-19 vaccination. N Engl J Med &#xa0;2021;384:2092&#x2013;2101.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8095372</ArticleId><ArticleId IdType="pubmed">33835769</ArticleId></ArticleIdList></Reference><Reference><Citation>Munker &#xa0;D, Veit &#xa0;T, Barton &#xa0;J, Mertsch &#xa0;P, M&#xfc;mmler &#xa0;C, Osterman &#xa0;A, et al. &#xa0;Pulmonary function impairment of asymptomatic and persistently symptomatic patients 4 months after COVID-19 according to disease severity. Infection &#xa0;2021. doi: 10.1007/s15010-021-01669-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s15010-021-01669-8</ArticleId><ArticleId IdType="pmc">PMC8318328</ArticleId><ArticleId IdType="pubmed">34322859</ArticleId></ArticleIdList></Reference><Reference><Citation>Grist &#xa0;JT, Chen &#xa0;M, Collier &#xa0;GJ, Raman &#xa0;B, AbuEid &#xa0;G, McIntyre &#xa0;A, et al. &#xa0;Hyperpolarized 129Xe MRI abnormalities in dyspneic participants 3 months after COVID-19 pneumonia: preliminary results. Radiology &#xa0;2021;301:E353&#x2013;E360.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8168952</ArticleId><ArticleId IdType="pubmed">34032513</ArticleId></ArticleIdList></Reference><Reference><Citation>Pretorius &#xa0;E, Vlok &#xa0;M, Venter &#xa0;C, Bezuidenhout &#xa0;JA, Laubscher &#xa0;GJ, Steenkamp &#xa0;J, et al. &#xa0;Persistent clotting protein pathology in long COVID/post-acute sequelae of COVID-19 (PASC) is accompanied by increased levels of antiplasmin. Cardiovasc Diabetol &#xa0;2021;20:172.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8381139</ArticleId><ArticleId IdType="pubmed">34425843</ArticleId></ArticleIdList></Reference><Reference><Citation>Pasini &#xa0;E, Corsetti &#xa0;G, Romano &#xa0;C, Scarabelli &#xa0;TM, Chen-Scarabelli &#xa0;C, Saravolatz &#xa0;L, et al. &#xa0;Serum metabolic profile in patients with long-Covid (PASC) syndrome: clinical implications. Front Med &#xa0;2021;8:714426.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8339407</ArticleId><ArticleId IdType="pubmed">34368201</ArticleId></ArticleIdList></Reference><Reference><Citation>Filbin &#xa0;MR, Mehta &#xa0;A, Schneider &#xa0;AM, Kays &#xa0;KR, Guess &#xa0;JR, Gentili &#xa0;M, et al. &#xa0;Longitudinal proteomic analysis of severe COVID-19 reveals survival-associated signatures, tissue-specific cell death, and cell-cell interactions. Cell Rep Med &#xa0;2021;2:100287.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8091031</ArticleId><ArticleId IdType="pubmed">33969320</ArticleId></ArticleIdList></Reference><Reference><Citation>Giloteaux &#xa0;L, Goodrich &#xa0;JK, Walters &#xa0;WA, Levine &#xa0;SM, Ley &#xa0;RE, Hanson &#xa0;MR. Reduced diversity and altered composition of the gut microbiome in individuals with myalgic encephalomyelitis/chronic fatigue syndrome. Microbiome &#xa0;2016;4:30.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4918027</ArticleId><ArticleId IdType="pubmed">27338587</ArticleId></ArticleIdList></Reference><Reference><Citation>Sivan &#xa0;M, Rayner &#xa0;C, Delaney &#xa0;B. Fresh evidence of the scale and scope of long covid. BMJ &#xa0;2021;373:n853.</Citation><ArticleIdList><ArticleId IdType="pubmed">33795224</ArticleId></ArticleIdList></Reference><Reference><Citation>Norton &#xa0;A, Olliaro &#xa0;P, Sigfrid &#xa0;L, Carson &#xa0;G, Paparella &#xa0;G, Hastie &#xa0;C, et al. &#xa0;Long COVID: tackling a multifaceted condition requires a multidisciplinary approach. Lancet Infect Dis &#xa0;2021;21:601&#x2013;602.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7906694</ArticleId><ArticleId IdType="pubmed">33548193</ArticleId></ArticleIdList></Reference><Reference><Citation>Abecassis &#xa0;A. Five priorities for universal COVID-19 vaccination. Lancet &#xa0;2021;398:285&#x2013;286.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8298009</ArticleId><ArticleId IdType="pubmed">34147157</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>